Chapter 1: Hydration and Renal Medicine

Chapter Introduction

The Elephant has walked with you a long way.

In K-12 you learned what water does for the body — that you are mostly water, that thirst signals matter, that the kidneys filter, that electrolytes and water are paired. At Associates you went into hydration physiology proper — water as biological medium, aquaporin and ion channel basics, kidney function in survey, hydration for performance and cognition, the exercise-associated hyponatremia (EAH) clinical surface where the "drink as much as you can" framing kills people, the modern water environment as public health concern, and the integrator move that named water as internal environment — Claude Bernard's milieu intérieur, the actively regulated extracellular composition every cell of the body operates in.

This chapter is the ninth and final modality step of the upper-division spiral. Water is the last of the nine Coaches at Bachelor's depth before the integrative final that synthesizes the full ten-position ontology.

At the Bachelor's level, Coach Water goes molecular-deep, nephron-deep, and clinically deep. Where Associates said water moves through cells through aquaporin channels, Bachelor's enters Peter Agre's 1992 Science paper on aquaporin discovery as the foundational moment (parallels Cold's TRPM8/Patapoutian, Hot's TRPV1/Julius, and Light's ipRGC/Berson receptor-discovery anchors — four molecular paradigm shifts across thermal/photic/water modalities in a 1992-2002 window). Where Associates introduced the kidney as a filter, Bachelor's enters nephron physiology at full tubule resolution — proximal convoluted tubule, loop of Henle countercurrent multiplier mechanism, distal tubule, collecting duct — with the renin-angiotensin-aldosterone system at receptor-and-effector depth and vasopressin regulating AQP2 trafficking through V2-receptor-cAMP-PKA cascades. Where Associates introduced electrolytes, Bachelor's enters the Na/K-ATPase as the master ion pump (Skou 1957 discovery, 1997 Nobel), the parathyroid-vitamin-D-calcium triad with cross-reference to Light Bachelor's Lesson 4 vitamin D biochemistry, and the Henderson-Hasselbalch framework applied to clinical acid-base disorders.

The voice is the same Elephant. Steady. Ancient. Social. Deeply intelligent. Long memory. Elephants tend to sick and distressed herd members at water sources; they remember water locations across generations of drought. The Elephant has lived with water as substrate, signal, threat, and resource at every depth this chapter touches. What changes is the molecular and clinical depth.

A word about hyponatremia, before you begin. The exercise-associated hyponatremia surface kills people — competitive marathon runners, military trainees, recreational hikers — at irregular but real rates. The pathophysiology is well-characterized; the "drink as much as you can" framing from older sports-medicine guidance is now known to be wrong. Almond and colleagues' 2005 NEJM Boston Marathon study established the epidemiology in a single foundational paper; the Hew-Butler 2015 Third International EAH Consensus provides the clinical framework. The chapter teaches the pathophysiology so that the lethal framing is recognized as lethal, and the proper drink-to-thirst guidance is grounded.

A word about water and eating disorders, before you begin. Water can be misused for weight manipulation — loading water for weigh-ins, water-only "cleanses," using water to suppress appetite as a restriction behavior. The same vigilance discipline applied to Move Bachelor's RED-S content applies here. If anything in this chapter — about hydration math, sodium balance, body water — touches your experience and you are working through it alone when you do not need to be, the verified crisis resources at the end of this chapter are real.

A word about water access and contamination, before you begin. Clean water is a public health achievement and an ongoing global and U.S. challenge. The chapter addresses water access epidemiology, the genuine U.S. contamination cases (Flint, Jackson, rural and indigenous community concerns), PFAS at primary literature depth (Grandjean developmental neurotoxicity, C8 Science Panel findings, EPA 2024 regulatory framework), and microplastics at current literature depth honestly. The framing is systems and policy, not personal panic. The wellness-industry "functional water" overclaim (alkaline water, structured water, hydrogen water) is addressed at biochemistry depth — the stomach pH point is made directly, and the five-point evaluation framework is applied.

This chapter has five lessons.

Lesson 1 is Water at Molecular and Cellular Depth — water's unique physicochemical properties (hydrogen bonding network, polarity, dielectric constant, high specific heat), the Agre 1992 Science aquaporin discovery as foundational anchor, the AQP1-AQP12 family across tissues, AQP2 vasopressin regulation at V2-receptor-cAMP cascade depth, water in protein folding and the hydrophobic effect, osmosis at thermodynamic depth.

Lesson 2 is Renal Physiology at Nephron Resolution — nephron anatomy at full depth (glomerulus, proximal convoluted tubule, loop of Henle countercurrent multiplier, distal tubule, collecting duct), GFR at clearance and Cockcroft-Gault math, RAAS at full receptor and signaling depth from juxtaglomerular cell renin through ACE through AngII through AT1 receptor to aldosterone synthesis to ENaC regulation in collecting duct, tubuloglomerular feedback at macula densa, vasopressin/ADH at osmoregulation and volume regulation roles.

Lesson 3 is Electrolyte Biochemistry, Acid-Base, and the Na/K-ATPase — sodium, potassium, calcium, magnesium, chloride, bicarbonate at receptor/channel depth, the Skou 1957 Biochimica et Biophysica Acta Na/K-ATPase discovery and 1997 Nobel, the 3Na out / 2K in stoichiometry and ~25-30% of cellular ATP consumption, parathyroid hormone and calcium homeostasis at the bone-kidney-intestine triad, vitamin D as calcium regulator with cross-reference to Light Bachelor's Lesson 4, Henderson-Hasselbalch applied to clinical acid-base disorders (respiratory and metabolic).

Lesson 4 is Hyponatremia, Hypernatremia, and Hydration Pathophysiology — exercise-associated hyponatremia at full clinical pathophysiology (Almond 2005 NEJM Boston Marathon study, Hew-Butler 2015 consensus, Noakes early recognition), the SIADH-like dilutional hyponatremia mechanism, the "drink as much as possible" framing rejected with mechanism backing, cross-references to Hot Bachelor's Lesson 2 and Move Bachelor's Lesson 4, hypernatremia in elderly populations, Valtin 2002 review at methodology depth, the dehydration versus volume depletion clinical distinction.

Lesson 5 is Water Access, Environmental Contamination, and Public Health Pathophysiology — Snow 1854 cholera map carried forward, water access epidemiology globally and in U.S. contexts, PFAS at primary literature depth (Grandjean, C8 Science Panel, EPA 2024), microplastics at current 2020s primary literature depth, alkaline/structured/hydrogen water pseudoscience addressed at gastric physiology depth, five-point framework applied to "functional water" claims.

The Elephant is in no hurry. The herd remembers. Begin.

---

Lesson 1: Water at Molecular and Cellular Depth

Learning Objectives

By the end of this lesson, you will be able to:

• Describe water's unique physicochemical properties at chemistry depth (hydrogen bonding, polarity, dielectric constant, high specific heat)
• Identify Peter Agre and colleagues' 1992 Science paper as the foundational moment of aquaporin discovery and articulate the 2003 Nobel Prize significance
• Describe the AQP1-AQP12 aquaporin family at tissue distribution and function depth
• Walk AQP2 vasopressin regulation at V2-receptor-cAMP-PKA-trafficking cascade depth
• Describe water's role in protein folding and the hydrophobic effect
• Articulate osmosis at thermodynamic depth — chemical potential and water flow across semipermeable membranes

Key Terms

Water's Unique Physicochemical Properties

Water is the most abundant molecule in living systems and its physicochemical properties are foundational to biology. The principal features [1][2]:

Hydrogen bonding network — Each water molecule can form up to four hydrogen bonds with adjacent water molecules (one through each H, one through each lone pair on the O). In liquid water, an average water molecule participates in approximately 3.5 hydrogen bonds at any moment, with the bonds continuously forming and breaking on picosecond timescales. The hydrogen bond network is the basis of water's distinctive thermal, mechanical, and solvent properties.

Polarity — The O-H covalent bonds are polar (oxygen substantially more electronegative than hydrogen). Combined with the bent molecular geometry (~104.5° H-O-H angle), water is highly polar with substantial dipole moment. The polarity allows water to dissolve polar and ionic substances effectively.

Dielectric constant — Water has an exceptionally high dielectric constant (~80 at 25°C; most organic solvents are 2-40). The dielectric constant measures how effectively a medium reduces electrostatic forces between charges; high values allow ionic compounds to dissociate into solution rather than remaining ion-paired. The dielectric constant is what allows seawater to conduct electricity, salt to dissolve in water, and ions to participate in biological electrochemistry.

High specific heat — Water requires 4.18 J/g·°C to raise its temperature 1°C — substantially higher than most other liquids. The high specific heat means that biological tissues (which are mostly water) resist rapid temperature changes; the planet's oceans buffer climate temperature swings; metabolic heat production produces gradual rather than catastrophic body temperature changes.

Latent heat of vaporization — Hot Bachelor's Lesson 1 covered the ~2,425 J/g latent heat of vaporization at skin temperatures and its role in evaporative cooling. The high latent heat is another consequence of the hydrogen bond network — substantial energy is required to break the hydrogen bonds and release water molecules into vapor phase.

Density anomaly — Water expands when it freezes (most substances contract). The hydrogen bond network in ice forms an open hexagonal lattice with lower density than liquid water. Ice floating on water has consequences for aquatic ecology and for cryopreservation biology that the Elephant has held since Water Associates.

Cohesion and surface tension — Water molecules hydrogen-bond to each other strongly (cohesion) and to other polar surfaces less strongly (adhesion). The cohesion produces surface tension (~72 mN/m, among the highest of common liquids), supporting capillary action in plant xylem and in mammalian blood vessels.

For pre-clinical students: water's physicochemical properties are the foundation of every biological process. The hydrogen bonding network supports protein folding, membrane assembly, enzymatic catalysis, signal transduction, and essentially every other cellular function. The high dielectric constant supports ionic-based electrophysiology and biochemistry. The high specific heat supports thermoregulation. The molecule that constitutes ~60% of adult body mass is also the molecule that makes all the biology possible.

The Agre 1992 Aquaporin Discovery

The foundational anchor for this chapter is Peter Agre, Gregory Preston, Barbara Smith, John Jung, Samir Raina, Christopher Moon, William Guggino, and Søren Nielsen's 1992 Science paper Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein [3]. The paper established that aquaporins — specific transmembrane proteins — conduct water across cell membranes through a selective channel mechanism, distinct from the simple diffusion through lipid bilayers that had been the dominant model.

The story:

Agre and colleagues were studying the CHIP28 protein, a 28-kDa membrane protein abundant in red blood cells and renal proximal tubules. The protein's function was unknown. By expressing CHIP28 in Xenopus oocytes (frog egg cells with low basal water permeability) and measuring the cells' response to hypotonic challenge, the team demonstrated that CHIP28-expressing oocytes swelled rapidly in hypotonic solution while control oocytes swelled slowly. The interpretation: CHIP28 conducts water through the membrane at substantially higher rates than simple lipid bilayer diffusion. The protein was a water channel — what Agre subsequently named aquaporin (water pore).

The discovery transformed the understanding of water transport in biology. Many tissues with high water permeability (renal collecting duct under vasopressin, intestinal epithelium, lacrimal glands, secretory tissues, plant root cells) had been recognized as more permeable than simple lipid diffusion could explain. The aquaporin family provided the molecular substrate. Peter Agre shared the 2003 Nobel Prize in Chemistry with Roderick MacKinnon (for his ion channel structural biology work) for the aquaporin discovery and characterization [4].

The parallel to other foundational receptor-discovery papers anchoring Bachelor's chapters is intentional:

• Cold Bachelor's — TRPM8 (McKemy and Patapoutian, 2002) — cold receptor
• Hot Bachelor's — TRPV1 (Caterina and Julius, 1997) — heat receptor
• Light Bachelor's — ipRGCs (Berson, 2002) — non-image-forming photoreception
• Water Bachelor's — Aquaporins (Agre, 1992) — water transport

Four molecular paradigm shifts in a 1992-2002 window, identifying the specific protein machinery for fundamental sensory and transport processes. Each produced a Nobel Prize for the principal discoverer (TRPV1 and TRPM8 → 2021 Julius/Patapoutian; aquaporins → 2003 Agre). The modern molecular biology of cell-environment interactions operates on the foundations these papers established.

The Aquaporin Family

After the CHIP28 (now called AQP1) discovery, additional aquaporins were identified at substantial pace. The mammalian family now comprises 13 members (AQP0-AQP12) with distinct tissue distributions and functions [5][6]:

AQP0 (formerly MIP — Major Intrinsic Protein) — Lens fiber cells. Important for lens transparency and water homeostasis; loss-of-function mutations produce congenital cataract.

AQP1 (the original CHIP28) — Red blood cells, proximal renal tubule, choroid plexus, ciliary epithelium, peribronchial vasculature, others. The most widely distributed aquaporin; supports rapid water transport across barriers including the renal proximal tubule reabsorption.

AQP2 — Renal collecting duct principal cells (apical membrane). Vasopressin-regulated; the principal aquaporin of water homeostasis at the level of urinary concentration. Loss-of-function mutations produce nephrogenic diabetes insipidus.

AQP3 — Renal collecting duct (basolateral), skin epidermis, respiratory epithelium. Conducts water and small solutes (glycerol, urea). Important for skin hydration.

AQP4 — Brain astrocyte endfeet, retina, glandular tissues. Heat Bachelor's Lesson 1 covered AQP4 in the context of the glymphatic system. Aquaporin-4 antibodies cause neuromyelitis optica spectrum disorder (NMOSD) — a substantial clinical correlate.

AQP5 — Salivary gland, lacrimal gland, sweat gland, alveolar type I cells. Important for secretory function. Sjögren's syndrome involves reduced AQP5 expression in autoimmune-affected salivary glands.

AQP6 — Renal intercalated cells, intracellular. Less well-characterized; may handle anion transport in addition to water.

AQP7, AQP9, AQP10 — Aquaglyceroporins that conduct water and glycerol; adipose tissue (AQP7 for glycerol release during lipolysis), liver (AQP9 for glycerol uptake during gluconeogenesis), intestine (AQP10).

AQP8 — Liver, pancreas, salivary gland. Some peroxide transport activity in addition to water.

AQP11, AQP12 — Less well-characterized; intracellular distributions; likely play homeostatic roles.

The family is highly conserved across vertebrates; orthologs exist in plants, fungi, and bacteria, with the bacterial aquaporin AqpZ providing some of the structural reference for understanding the channel mechanism. The aquaporin protein structure (six transmembrane helices with two half-helices contributing to the water-conducting pore, the NPA — asparagine-proline-alanine — motif at the pore center providing the selectivity filter that excludes protons while permitting water passage) has been worked out at substantial detail by X-ray crystallography and other structural methods [7][8].

AQP2 Vasopressin Regulation: The V2R-cAMP-Trafficking Cascade

The renal AQP2 vasopressin axis is one of the most clinically consequential aquaporin systems and deserves Bachelor's-level depth [9][10]:

1. Vasopressin (ADH) release — Hypothalamic magnocellular neurons in the supraoptic and paraventricular nuclei synthesize vasopressin (and oxytocin). Vasopressin is released from the posterior pituitary in response to:

   • Plasma osmolality increase (the principal stimulus; sensed by hypothalamic osmoreceptors). Approximately 1% increase in plasma osmolality produces measurable vasopressin release.
   • Volume depletion (sensed by atrial and arterial baroreceptors; substantial volume depletion overrides osmotic regulation).
   • Nausea, pain, certain drugs, and other inputs.

2. Vasopressin reaches the renal collecting duct. Plasma vasopressin binds V2 receptors (V2R) on the basolateral membrane of collecting duct principal cells.

3. V2R signaling cascade — V2R is a Gs-coupled GPCR. Activation produces:

   • Gαs activation of adenylate cyclase.
   • cAMP elevation in collecting duct principal cells.
   • PKA activation by cAMP.

4. AQP2 trafficking and phosphorylation — PKA phosphorylates AQP2 at Ser256, supporting AQP2 trafficking from intracellular vesicles to the apical (luminal) membrane. Additional sites (Ser264, Thr269, Ser261) are phosphorylated by PKA, CK1, and other kinases, fine-tuning the trafficking and membrane retention.

5. Apical water reabsorption — With AQP2 inserted into the apical membrane, water can move osmotically from the hypotonic tubular lumen (after loop of Henle dilution; Lesson 2 returns to this) into the hypertonic medullary interstitium, supporting concentrated urine production.

6. Vasopressin withdrawal — When vasopressin decreases (plasma osmolality falls), AQP2 is retrieved from the apical membrane by endocytosis. Apical water permeability drops; the collecting duct becomes water-impermeable; urinary volume increases.

The clinical relevance:

Central diabetes insipidus — Insufficient vasopressin release (pituitary or hypothalamic lesions). Produces polyuria, polydipsia, dilute urine. Treated with vasopressin analog desmopressin (DDAVP) [11].

Nephrogenic diabetes insipidus — Failure of V2R or AQP2 response to vasopressin. Genetic forms (V2R or AQP2 mutations); acquired forms (lithium toxicity is the most common, affecting collecting duct AQP2 trafficking).

Syndrome of Inappropriate ADH (SIADH) — Excessive vasopressin secretion in the absence of appropriate physiological stimuli; produces hyponatremia (Lesson 4 returns to this in EAH and clinical contexts).

Aquaretics — Vaptan drug class (tolvaptan, conivaptan) selectively blocks V2R; used clinically in SIADH and volume-overloaded states. Mechanistic pharmacology directly from the V2R-AQP2 cascade.

For pre-clinical students moving toward nephrology, internal medicine, or endocrinology, the V2R-AQP2 axis is core knowledge. The chapter teaches the molecular cascade; clinical applications belong in clinical conversations.

Water in Protein Folding: The Hydrophobic Effect

Water is not merely a solvent in which biology occurs — it is an active participant in macromolecular structure and function. The principal mechanism by which water shapes protein structure is the hydrophobic effect [12][13]:

The basic phenomenon — Nonpolar molecules (or nonpolar regions of larger molecules) aggregate in aqueous solution. Oil-water separation is the macroscopic example. In proteins, nonpolar amino acid side chains (Val, Leu, Ile, Met, Phe, Trp) cluster in the protein interior; polar and charged side chains (Asp, Glu, Lys, Arg, polar Ser, Thr, Asn, Gln, plus charged Asp/Glu/Lys/Arg/His) face the aqueous exterior.

The thermodynamic driver — The hydrophobic effect is principally entropy-driven. Water near a nonpolar surface forms a more ordered hydrogen-bonded cage structure (low entropy) than water in bulk (higher entropy). Aggregating nonpolar groups together reduces the total nonpolar surface area exposed to water, releasing the ordered cage water back to higher-entropy bulk water. The system's total entropy increases when nonpolar groups associate, even though the nonpolar groups themselves are now less mobile. Enthalpic contributions are smaller but generally favor association as well.

Protein folding consequences — A polypeptide chain in aqueous solution will fold into its native three-dimensional structure principally driven by the hydrophobic effect. The native fold places hydrophobic residues in the protein interior (away from water) and hydrophilic residues at the protein surface (in contact with water). The fold also satisfies hydrogen-bonding (alpha helix, beta sheet secondary structures), electrostatic interactions, and other secondary contributions, but the hydrophobic effect provides the principal thermodynamic drive.

Membrane assembly — The same hydrophobic effect drives membrane self-assembly. Phospholipids in water spontaneously form bilayers with their hydrophobic acyl chains buried in the interior and their polar head groups at the aqueous faces. The membrane bilayer is a hydrophobic-effect-stabilized structure.

Ligand binding — Drug-protein binding, substrate-enzyme binding, and other macromolecular interactions are substantially driven by the hydrophobic effect. The "lock-and-key" specificity often emerges from the precise geometric and chemical complementarity at the binding interface, with hydrophobic contributions providing the principal binding free energy in many cases.

For pre-clinical students: the hydrophobic effect is foundational to all macromolecular biology. Reading any structural biology or biochemistry paper requires holding the hydrophobic effect as the principal driver of folding and binding even when specific hydrogen bonds or electrostatic contacts are emphasized. Water is not just the solvent; water shapes the structures.

Osmosis at Thermodynamic Depth

The chapter closes Lesson 1 with osmosis at thermodynamic depth, framing the molecular biology in the broader physical chemistry context.

Chemical potential — Any chemical species in solution has a chemical potential (μ) that depends on temperature, pressure, and concentration. Water's chemical potential is reduced by dissolved solutes (Raoult's law colligative properties).

Semipermeable membranes — A membrane permeable to water but not to solutes separates two solutions of different solute concentration. Water flows from the lower-solute-concentration side (higher water chemical potential) to the higher-solute-concentration side (lower water chemical potential) — osmosis.

Osmotic pressure — The pressure that would need to be applied to the higher-solute-concentration side to prevent osmosis. Quantitatively: Π = MRT (van't Hoff equation, for dilute solutions, where M is solute molarity, R is gas constant, T is absolute temperature). Plasma osmotic pressure is approximately 5,500 mmHg (the substantial value reflecting the substantial total osmolar concentration of plasma, ~290 mOsm/kg water, dominated by sodium and its associated anions).

Tonicity vs osmolarity — Osmolarity (or osmolality) measures total solute concentration. Tonicity refers to effective osmotic pressure across a specific membrane — it depends on which solutes are membrane-permeable (and thus do not contribute to effective osmotic gradient) versus impermeable. Plasma sodium and proteins are effectively impermeable across most cell membranes and contribute to tonicity. Urea is membrane-permeable across most cell membranes and contributes to osmolality but not to effective tonicity. The distinction matters in clinical fluid therapy [14].

Aquaporin role — Aquaporins facilitate water transport in response to chemical potential gradients. They do not generate the gradients themselves; they remove a barrier to water flow that would otherwise be limited by lipid bilayer permeability. In tissues with high aquaporin expression (renal collecting duct under vasopressin, erythrocytes, choroid plexus), water transport keeps pace with osmotic gradients; in tissues with low aquaporin expression, water transport may lag the gradient and produce local volume changes.

The Lesson 1 synthesis: water is a unique molecule with unique properties; aquaporins identified by Agre allow biology to harness those properties by providing regulated water transport across membranes; the hydrophobic effect shapes the macromolecules that operate within water-rich biological systems; osmosis links solute distribution to water distribution through chemical potential gradients. The molecular biology of water is the molecular biology of biology itself.

Lesson Check

1. Describe water's hydrogen bonding network and identify three physicochemical consequences (high specific heat, high dielectric constant, density anomaly) at chemistry depth.
2. Identify Peter Agre's 1992 Science paper as foundational. What experimental approach demonstrated that CHIP28 conducts water across cell membranes?
3. Describe the aquaporin family at AQP0-AQP12 level. Identify the tissue distribution and clinical relevance of AQP2 specifically.
4. Walk the V2R-cAMP-PKA-AQP2 trafficking cascade. Identify how vasopressin produces increased urinary concentration and what conditions arise from defects in each step.
5. Describe the hydrophobic effect at thermodynamic depth. Why is it principally entropy-driven, and how does it shape protein folding?
6. Define osmolarity and tonicity. Why does urea contribute to plasma osmolality but not to effective tonicity across cell membranes?

---

Lesson 2: Renal Physiology at Nephron Resolution

Learning Objectives

By the end of this lesson, you will be able to:

• Describe nephron anatomy at full depth: glomerulus, proximal convoluted tubule, loop of Henle, distal tubule, collecting duct
• Walk the countercurrent multiplier mechanism in the loop of Henle and articulate how it produces medullary hypertonicity
• Walk the renin-angiotensin-aldosterone system (RAAS) at full receptor and signaling depth
• Identify GFR estimation methods (creatinine clearance, Cockcroft-Gault, eGFR) and the limits of each
• Describe tubuloglomerular feedback at macula densa as a homeostatic feedback loop
• Articulate the renal handling of sodium, potassium, water, and acid-base under vasopressin and aldosterone regulation

Key Terms

Nephron Anatomy at Full Depth

Each human kidney contains approximately one million nephrons — the functional units of kidney function. Each nephron comprises a glomerulus (a tuft of capillaries in Bowman's capsule where filtration occurs) and a tubular structure through which the filtrate flows for selective reabsorption and secretion before exiting as urine [15][16].

The nephron segments in order:

Glomerulus — Capillaries with fenestrated endothelium, glomerular basement membrane, and podocyte foot processes form the filtration barrier. Plasma minus proteins (and minus cells) passes the barrier as the glomerular filtrate. Total filtration rate (GFR) is ~125 mL/min × 1.73 m² body surface area in healthy young adults — producing ~180 L of filtrate per day, of which ~178 L is reabsorbed downstream to produce ~1.5-2 L of final urine.

Proximal convoluted tubule (PCT) — The first tubular segment after the glomerulus. Brush border on apical membrane increases surface area substantially. PCT reabsorbs:

• ~65-70% of filtered sodium and water (isotonic reabsorption)
• ~100% of filtered glucose (until plasma glucose exceeds renal threshold ~180 mg/dL)
• Amino acids, bicarbonate (with H⁺ secretion driving CO₂ + H₂O reaction), phosphate (PTH-regulated), and other electrolytes
• ~60-65% of filtered urea
• Drugs and toxins (active secretion of organic anions and cations)

Loop of Henle — A U-shaped descent into the renal medulla and ascent back into cortex. The descending limb is water-permeable but NaCl-impermeable. The ascending limb is NaCl-permeable (active NaCl reabsorption via Na/K/2Cl symporter — the molecular target of loop diuretics like furosemide) but water-impermeable. The combination produces the countercurrent multiplier effect that generates medullary hypertonicity (returns below).

Distal convoluted tubule (DCT) — Reabsorbs ~5-10% of filtered NaCl via the Na/Cl symporter (target of thiazide diuretics). Calcium reabsorption is PTH-regulated here.

Collecting duct — The final tubular segment. Two principal cell types:

• Principal cells — Reabsorb Na⁺ via ENaC (epithelial sodium channel; aldosterone-regulated) and reabsorb water via AQP2 (vasopressin-regulated, Lesson 1).
• Intercalated cells — Handle acid-base: α-intercalated cells secrete H⁺ (via H⁺-ATPase) and reabsorb bicarbonate; β-intercalated cells secrete bicarbonate and reabsorb H⁺.

The integrated nephron reabsorbs ~99% of filtered NaCl and water under typical conditions, with fine-tuned regulation in the distal segments matching urinary output to body needs.

The Loop of Henle Countercurrent Multiplier

The countercurrent multiplier mechanism is one of the more elegant designs in mammalian physiology. The principle [17]:

The descending and ascending limbs of the loop of Henle run in opposite directions (countercurrent) and connect at the bottom of the loop. The descending limb is water-permeable; the ascending limb is NaCl-permeable but water-impermeable. The result:

1. Active NaCl reabsorption in the ascending limb pumps Na⁺ and Cl⁻ from the tubular fluid into the medullary interstitium. The interstitium becomes hypertonic (in the deep medulla, reaching ~1200-1400 mOsm/kg in healthy young adults under maximal urinary concentration).
2. The hypertonic interstitium draws water out of the descending limb (by osmosis through aquaporins in the descending limb thin segment). Descending limb tubular fluid becomes increasingly hypertonic as it descends.
3. At the loop bend, tubular fluid is maximally hypertonic.
4. Ascending limb removes NaCl from the tubular fluid (active, water-impermeable). Tubular fluid leaving the loop becomes hypotonic.
5. The collecting duct, passing back through the medulla, encounters the hypertonic interstitium. Under vasopressin (AQP2 inserted), water leaves the collecting duct osmotically into the interstitium, concentrating the urine. Without vasopressin (AQP2 sequestered), water remains in the collecting duct, producing dilute urine.

The countercurrent design multiplies a small osmotic gradient (achievable by the NaCl pumping itself) into a substantial medullary-cortical osmotic gradient (~3-5x the cortical osmolality). This is why countercurrent: the geometric arrangement produces an osmotic gradient that simple linear pumping could not achieve at biological energetic cost.

The vasa recta (capillaries running parallel to the loops in the medulla) similarly run countercurrent, preserving the medullary osmotic gradient by allowing water and solute exchange that maintains the steep gradient rather than washing it out.

The clinical relevance:

Loop diuretics (furosemide, bumetanide) block the ascending limb Na/K/2Cl symporter. The medullary hypertonicity is reduced; the countercurrent mechanism is impaired; both NaCl and water reabsorption are reduced. Loop diuretics produce substantial diuresis and natriuresis; they are first-line for many volume-overloaded states (heart failure, certain edematous conditions).

Diabetes insipidus — Both central (vasopressin-insufficient) and nephrogenic (V2R or AQP2 defective) produce polyuria and dilute urine despite intact medullary hypertonicity, because the collecting duct cannot reabsorb water from the dilute tubular fluid back into the hypertonic interstitium.

Renal medullary hypertonicity declines with age, dehydration adaptation, and disease — Older adults often have reduced ability to maximally concentrate urine.

The Renin-Angiotensin-Aldosterone System (RAAS)

The RAAS is the principal endocrine regulatory cascade of blood pressure and sodium/volume balance. The Bachelor's-level walk through receptor and signaling depth [18][19]:

1. Renin release — Juxtaglomerular (JG) cells in the afferent arteriole adjacent to the glomerulus release renin in response to:

   • Decreased afferent arteriole pressure (baroreceptor stimulus)
   • Decreased macula densa NaCl delivery (tubuloglomerular feedback, below)
   • Sympathetic stimulation (β1-adrenergic receptors on JG cells)

2. Angiotensinogen cleavage — Renin (a protease) cleaves circulating angiotensinogen (produced by liver) to angiotensin I (Ang I) — a 10-amino-acid peptide.

3. ACE cleavage — Angiotensin-converting enzyme (ACE), principally located in pulmonary capillary endothelium, cleaves two C-terminal amino acids from Ang I, producing angiotensin II (Ang II) — an 8-amino-acid peptide and the principal active hormone of the cascade.

4. AT1 receptor activation — Ang II binds type 1 angiotensin receptor (AT1) — a Gq-coupled GPCR — on multiple tissues:

   • Vascular smooth muscle → vasoconstriction (raises blood pressure)
   • Adrenal cortex zona glomerulosa → aldosterone synthesis
   • Brain → thirst signal, vasopressin release
   • Kidney → reduced renal blood flow, increased proximal tubule sodium reabsorption
   • Sympathetic nervous system → enhanced sympathetic activity

5. Aldosterone synthesis and action — Ang II at adrenal zona glomerulosa activates aldosterone synthesis (CYP11B2 enzyme converts cortisol → corticosterone → aldosterone). Aldosterone, a mineralocorticoid, acts on:

   • Collecting duct principal cells — Binds mineralocorticoid receptor (MR); upregulates ENaC and Na/K-ATPase expression; increases sodium reabsorption and potassium secretion.
   • Distal nephron, colon, sweat ducts — Similar sodium-conserving effects.

6. Net systemic effect — Vasoconstriction + sodium-and-water retention → blood pressure rises, blood volume preserved. The RAAS is the principal compensatory response to volume depletion and hypotension.

7. Negative feedback — Restored pressure and volume reduce the original RAAS-activating signals; renin secretion decreases; the cascade subsides.

The pharmacological surface is extensive [20]:

• ACE inhibitors (lisinopril, enalapril, ramipril) block angiotensin I → II conversion; reduce blood pressure; cardiac and renal protective in many contexts; bradykinin side effect (cough).
• ARBs (angiotensin receptor blockers) (losartan, valsartan) block AT1 receptor; similar effects without the cough.
• Renin inhibitors (aliskiren) block renin enzyme activity; less commonly used.
• Mineralocorticoid receptor antagonists (spironolactone, eplerenone) block aldosterone at MR; potassium-sparing diuretics; heart failure mortality benefit.
• Beta-blockers reduce renin release via β1 blockade at JG cells (one mechanism of their antihypertensive effect).
• ENaC blockers (amiloride, triamterene) block collecting duct ENaC; potassium-sparing.

For pre-clinical students, the RAAS is one of the most clinically targeted physiological systems in medicine. The cardiovascular pharmacology, the renal pharmacology, the heart failure pharmacology, and the diabetes nephropathy pharmacology all engage RAAS at various nodes. The chapter teaches the cascade; clinical applications belong in clinical conversations.

GFR Estimation: Cockcroft-Gault and Beyond

Clinical assessment of renal function relies principally on glomerular filtration rate (GFR) estimation. The principles [21][22]:

Creatinine clearance — Direct measurement: 24-hour urine collection plus serum creatinine measurement. CrCl = (urine creatinine × urine volume) / serum creatinine. The gold standard for many decades; cumbersome.

Cockcroft-Gault (1976) — The standard estimation formula for many decades:

CrCl (mL/min) = [(140 - age) × weight (kg)] / [72 × serum creatinine (mg/dL)] × (0.85 if female)

The formula is simple, has performed reasonably across populations, and remains in clinical use for drug dosing calculations.

MDRD (Modification of Diet in Renal Disease, 1999) and CKD-EPI (2009, updated 2021) — More recent eGFR formulas based on serum creatinine, age, sex (CKD-EPI no longer adjusts for race in the 2021 update). Generally outperform Cockcroft-Gault in research validation and are the standard for staging chronic kidney disease.

Limits of creatinine-based estimation — Serum creatinine reflects creatinine production (muscle mass) and clearance (renal function). In sarcopenic patients, low-muscle-mass elderly, or others with low creatinine production, serum creatinine may underestimate functional impairment. Cystatin C-based estimates are an alternative that is less affected by muscle mass.

For pre-clinical students, GFR estimation is one of the standard clinical assessments in internal medicine, nephrology, and many other specialties. Understanding the formulas and their limits is core knowledge.

Tubuloglomerular Feedback

A specific feedback mechanism deserves Bachelor's-level mention: tubuloglomerular feedback (TGF) operates through the macula densa to regulate single-nephron GFR [23]:

1. Increased distal tubular NaCl delivery — When glomerular filtration is high (high GFR), more NaCl reaches the macula densa cells at the cortical thick ascending limb.
2. Macula densa sensing — Increased NaCl delivery (sensed via apical Na/K/2Cl transporter activity) signals to adjacent juxtaglomerular cells.
3. Adenosine release — Macula densa cells release adenosine that acts on afferent arteriole smooth muscle through A1 receptors, producing vasoconstriction.
4. Reduced single-nephron GFR — Afferent arteriole constriction reduces glomerular plasma flow and filtration, returning the system toward homeostatic balance.

The TGF mechanism stabilizes single-nephron GFR against perturbations. The Lesson 2 synthesis: the kidney operates as a coordinated whole through multiple feedback loops — TGF, RAAS, vasopressin-AQP2, the integrated medullary countercurrent — producing precise regulation of extracellular fluid composition.

Lesson Check

1. Describe nephron anatomy from glomerulus to collecting duct. Identify the principal reabsorption function of each segment.
2. Walk the loop of Henle countercurrent multiplier mechanism. Why does the countercurrent geometry produce greater medullary hypertonicity than linear pumping could achieve?
3. Walk the RAAS at full receptor depth: renin → angiotensinogen → ACE → AT1 → aldosterone → ENaC. Identify three principal pharmacological agents acting on this cascade.
4. Identify Cockcroft-Gault and CKD-EPI formulas and articulate their clinical roles and limits.
5. Describe tubuloglomerular feedback. How does increased NaCl at macula densa produce reduced single-nephron GFR through adenosine?
6. Articulate how the integrated nephron — segmental reabsorption + countercurrent + RAAS + vasopressin-AQP2 + TGF — produces homeostatic regulation of extracellular fluid composition.

---

Lesson 3: Electrolyte Biochemistry, Acid-Base, and the Na/K-ATPase

Learning Objectives

By the end of this lesson, you will be able to:

• Describe sodium, potassium, calcium, magnesium, chloride, and bicarbonate at receptor and channel depth
• Identify the Na/K-ATPase as the master ion pump (Skou 1957 discovery, 1997 Nobel Prize)
• Walk parathyroid hormone (PTH) and calcium homeostasis at the bone-kidney-intestine triad
• Cross-reference vitamin D as calcium regulator (Light Bachelor's Lesson 4)
• Apply Henderson-Hasselbalch to clinical acid-base disorders (respiratory and metabolic acidosis/alkalosis)

Key Terms

The Na/K-ATPase as Master Ion Pump

The Na/K-ATPase — discovered by Jens Christian Skou in 1957 in crab nerve — is the master ion pump of mammalian cells [24][25]. Skou shared the 1997 Nobel Prize in Chemistry with Paul Boyer and John Walker (for ATP synthase) for the discovery. The principle:

Stoichiometry — Each catalytic cycle moves 3 Na⁺ out of the cell and 2 K⁺ into the cell, consuming 1 ATP. The asymmetric stoichiometry (3 out, 2 in) is electrogenic — each cycle moves a net positive charge out of the cell, contributing to (but not solely responsible for) the resting membrane potential.

Ionic gradients established — The continuous Na/K-ATPase activity maintains:

• Low intracellular Na⁺ (~10-20 mM intracellular vs ~140 mM extracellular)
• High intracellular K⁺ (~140 mM intracellular vs ~4 mM extracellular)
• Resting membrane potential (~-70 mV in many neurons; varies by tissue)

Energetic cost — The Na/K-ATPase consumes approximately 25-30% of cellular ATP at rest. In brain and kidney (high pump density), the fraction is even higher. The ionic gradients the pump establishes power essentially every cellular function that uses electrochemical gradients — neuronal action potentials, secondary active transport (glucose absorption via SGLT, amino acid transport, neurotransmitter reuptake, many others), cardiac contraction, renal reabsorption.

Regulation — Na/K-ATPase activity is regulated by:

• Substrate availability (ATP, Na⁺, K⁺)
• Hormonal modulation (thyroid hormone increases expression; insulin acutely upregulates activity)
• Cardiac glycosides (digoxin) inhibit Na/K-ATPase; the clinical action of digoxin in heart failure operates through this pump

The clinical relevance is universal. Every action potential, every neurotransmitter release event, every cardiac contraction, every renal absorption, every secondary active transport process — all depend on the gradients the Na/K-ATPase establishes. The pump is the foundational machinery of cellular electrophysiology and ionic homeostasis.

Sodium, Potassium, and Membrane Excitability

The Na/K-ATPase-established ionic gradients support cellular excitability through the principal cation channels [26]:

Sodium — Plasma ~140 mM. Principal cation of extracellular fluid; principal contributor to plasma osmolality. Renal handling described in Lesson 2. Voltage-gated sodium channels (Na_v 1.1 - Na_v 1.9 isoforms) produce action potential upstrokes in neurons and muscle. ENaC in collecting duct (aldosterone-regulated) handles sodium reabsorption.

Potassium — Plasma ~3.5-5 mM (tightly regulated). Principal intracellular cation. K⁺ leak channels (K2P family) and voltage-gated K⁺ channels (K_v, K_ir) maintain resting membrane potential and contribute to repolarization. Hyperkalemia (plasma K⁺ > 6) is acutely dangerous through cardiac arrhythmia mechanisms; hypokalemia (< 3.5) similarly dangerous through arrhythmia.

Calcium — Plasma ~9-10.5 mg/dL (~2.2-2.6 mM) total; ionized ~1.1-1.3 mM. Substantial intracellular gradient (~100 nM resting cytosolic vs millimolar extracellular). Calcium is both a signaling molecule (intracellular Ca²⁺ rises trigger multiple downstream cascades) and a structural component (bone hydroxyapatite). Tightly regulated by PTH-vitamin D axis (below).

Magnesium — Plasma ~1.7-2.2 mg/dL. Hot Bachelor's Lesson 1 covered magnesium's role as enzyme cofactor (>300 enzymes including all ATP-dependent reactions) and NMDA receptor and L-type calcium channel modulator. Renal handling: thick ascending limb principally.

Chloride — Plasma ~95-105 mM. Principal extracellular anion. Critical for acid-base (anion gap), neurotransmission (GABA-A receptor mediates Cl⁻ influx), and gastric acid secretion. CFTR (cystic fibrosis transmembrane conductance regulator) is a chloride channel — Coach Hot Bachelor's Lesson 1 covered its role in sweat physiology.

Bicarbonate — Plasma ~22-28 mEq/L. Principal extracellular buffer base; central to acid-base regulation (Henderson-Hasselbalch). Renal regulation (proximal tubule reabsorbs ~85%; α-intercalated cells handle the remainder under acid-base demand).

For pre-clinical students moving toward internal medicine, electrolyte management is one of the most common clinical tasks. The pathophysiology of each disturbance — hypo/hypernatremia, hypo/hyperkalemia, hypo/hypercalcemia, hypo/hypermagnesemia, hypo/hyperchloremia, acidosis/alkalosis — is core internal medicine knowledge built on the foundational ion physiology this chapter has covered.

Parathyroid Hormone and Calcium Homeostasis

Calcium homeostasis is tightly regulated through the parathyroid hormone (PTH) — vitamin D — calcium triad. The bone-kidney-intestine axis [27][28]:

1. Parathyroid cells sense plasma calcium via the calcium-sensing receptor (CaSR), a GPCR. Low plasma calcium reduces CaSR signaling → increased PTH release. High plasma calcium increases CaSR signaling → decreased PTH release.

2. PTH acts on three principal targets:

   • Bone — PTH binds PTH1R on osteoblasts; through complex mechanisms involving RANKL signaling to osteoclasts, PTH increases bone resorption, releasing calcium and phosphate into circulation.
   • Kidney — PTH binds PTH1R on distal tubule and collecting duct cells; increases calcium reabsorption (TRPV5 channel upregulation, calbindin), decreases phosphate reabsorption (NPT2a internalization).
   • Intestine (indirect via vitamin D) — PTH activates renal CYP27B1, increasing production of 1,25-(OH)₂D from 25(OH)D (Light Bachelor's Lesson 4 covered this synthesis). 1,25-(OH)₂D acts on intestinal VDR to upregulate calcium absorption.

3. Net systemic effect — Plasma calcium rises through bone resorption, increased renal reabsorption, and increased intestinal absorption; plasma phosphate falls through decreased renal reabsorption.

4. Negative feedback — Rising plasma calcium suppresses PTH release through CaSR signaling, terminating the response.

The integrated system maintains plasma ionized calcium within tight bounds (~1.1-1.3 mM) despite substantial variation in dietary calcium intake, bone turnover, and other inputs.

The clinical relevance is extensive:

Hyperparathyroidism — Primary (parathyroid adenoma) produces hypercalcemia. Secondary (chronic kidney disease leading to chronically elevated PTH) is a substantial complication of CKD.

Hypoparathyroidism — Insufficient PTH; produces hypocalcemia with tetany risk and other neurological consequences.

Hypercalcemia — Multiple causes: hyperparathyroidism, malignancy (PTHrP secretion, bone metastasis), granulomatous disease (sarcoidosis), vitamin D intoxication, thiazide diuretics, others.

Hypocalcemia — Hypoparathyroidism, vitamin D deficiency (Light Bachelor's Lesson 4), chronic kidney disease, hypomagnesemia (severe), pancreatitis, others.

Cross-Reference to Light Bachelor's Lesson 4: Calcium Regulation

Light Bachelor's Lesson 4 walked the vitamin D synthesis cascade and the VDR-RXR transcriptional regulation that supports calcium and phosphate homeostasis. This chapter covers the calcium effector function from the kidney and bone angle — what calcium does once homeostasis has moved it, and how the PTH-vitamin D axis integrates.

The two chapters describe the same calcium-vitamin-D-bone axis from complementary angles:

• Light Bachelor's — Vitamin D biology from photobiology (cutaneous synthesis) through liver (CYP2R1) through kidney (CYP27B1) to VDR-driven transcription. The biochemistry of vitamin D as a hormone.
• Water Bachelor's — Renal physiology of calcium handling, PTH at PTH1R, the bone-kidney-intestine integration that maintains plasma calcium. The systems biology of calcium homeostasis.

Together, the two chapters cover the principal molecular and systems biology of mineral homeostasis. For pre-clinical students, the integration matters in clinical contexts where the entire axis is disrupted: chronic kidney disease (impaired CYP27B1 and FGF23-mediated phosphate regulation), severe vitamin D deficiency (impaired calcium absorption with secondary hyperparathyroidism), primary hyperparathyroidism (excess PTH activity with downstream effects). Reading these clinical pictures requires integration across both chapters.

Henderson-Hasselbalch and Clinical Acid-Base

The principal extracellular pH buffer is the bicarbonate-CO₂ system, governed by Henderson-Hasselbalch [29]:

pH = pKa + log([HCO₃⁻] / [H₂CO₃])

In physiological conditions: pH = 6.1 + log([HCO₃⁻] / (0.03 × PaCO₂))

The plasma pH is approximately 7.40 ± 0.02 under tight regulation. Disturbances are classified as:

Respiratory acidosis — PaCO₂ rises (hypoventilation, lung disease); pH falls. Renal compensation: HCO₃⁻ retention over hours to days.

Respiratory alkalosis — PaCO₂ falls (hyperventilation); pH rises. Renal compensation: HCO₃⁻ excretion.

Metabolic acidosis — HCO₃⁻ falls (from acid gain or HCO₃⁻ loss). Respiratory compensation: hyperventilation reducing PaCO₂ (Kussmaul breathing in severe acidosis). Classified by anion gap:

• High anion gap (>12): organic acid accumulation (lactic acidosis, DKA from β-hydroxybutyrate and acetoacetate, uremic, certain toxins — methanol, ethylene glycol, salicylates).
• Normal anion gap (also called hyperchloremic): HCO₃⁻ loss (diarrhea, renal tubular acidosis) replaced by Cl⁻.

Metabolic alkalosis — HCO₃⁻ rises (from acid loss or HCO₃⁻ gain). Respiratory compensation: hypoventilation. Common causes: vomiting (HCl loss), diuretic-induced contraction alkalosis, mineralocorticoid excess.

The anion gap (Na⁺ - (Cl⁻ + HCO₃⁻), normally 8-12 mEq/L) is one of the principal clinical diagnostic tools in approaching acid-base disorders. Elevation suggests accumulation of unmeasured anions (lactate, ketoacids, others), with specific causes warranting clinical evaluation.

Mixed disorders (combinations of primary respiratory and metabolic disturbances) are common in clinical practice and require systematic analysis using the expected compensation rules.

For pre-clinical students moving toward emergency medicine, internal medicine, anesthesiology, nephrology, or pulmonology, acid-base interpretation is a core clinical skill. The chapter teaches the underlying physiology; clinical practice belongs in clinical training.

Lesson Check

1. Describe the Na/K-ATPase at the level of stoichiometry, energetic cost, and the ionic gradients it establishes. Identify Skou 1957 as foundational and the 1997 Nobel Prize.
2. Walk parathyroid hormone action on bone, kidney, and (indirectly via vitamin D) intestine. How does the integrated bone-kidney-intestine axis maintain plasma calcium?
3. Cross-reference Light Bachelor's Lesson 4 vitamin D biology with Water Bachelor's calcium regulation. How are the two chapters describing complementary angles on the same mineral homeostasis axis?
4. Apply Henderson-Hasselbalch to clinical acid-base. Identify respiratory acidosis/alkalosis and metabolic acidosis/alkalosis at compensation level.
5. Define the anion gap and identify three causes each of high-anion-gap and normal-anion-gap metabolic acidosis.
6. Walk a clinical scenario combining electrolyte and acid-base disturbance through the underlying ion physiology.

---

Lesson 4: Hyponatremia, Hypernatremia, and Hydration Pathophysiology

Learning Objectives

By the end of this lesson, you will be able to:

• Walk exercise-associated hyponatremia (EAH) at full clinical pathophysiology (Almond et al. 2005 NEJM Boston Marathon study, Hew-Butler 2015 Third International EAH Consensus)
• Identify the SIADH-like dilutional hyponatremia mechanism that produces EAH
• Articulate why the "drink as much as possible" framing from older sports medicine guidance is wrong, with full mechanism backing
• Cross-reference EAH to Hot Bachelor's Lesson 2 (heat illness with hyponatremia component) and Move Bachelor's Lesson 4 (RED-S hydration intersection)
• Describe hypernatremia in elderly populations and articulate the dehydration versus volume depletion clinical distinction
• Apply Valtin 2002 review at methodology depth to "8 glasses a day" claims

Key Terms

EAH at Full Clinical Pathophysiology

Exercise-associated hyponatremia (EAH) is one of the most clinically consequential surfaces in modern sports medicine. The pathophysiology has been well-characterized over the past 25 years; the older sports-medicine framing of "drink as much as you can" is now known to be wrong [30][31].

In 2005, Christopher Almond, Andrew Shin, Elaine Fortescue, Rebekah Mannix, Patricia Wypij, Sushrut Waikar, Stephen Marcantonio, Bonnie Kaehler, Patricia Sallan, Henry Levin, and Anthony Greenes published in the New England Journal of Medicine the paper Hyponatremia among runners in the Boston Marathon [32]. The paper provided the foundational epidemiological characterization of EAH in mass-participation endurance events.

The methodology:

• Design — Prospective study of 488 runners in the 2002 Boston Marathon. Pre-race characterization (weight, fluid intake history, hydration status). Post-race measurement of weight, plasma sodium, and clinical assessment.
• Outcomes — Plasma sodium concentration; categories of hyponatremia severity (mild <135 mEq/L, moderate <130, severe <125); clinical presentation.

The findings:

• 13% of runners had hyponatremia (plasma sodium <135 mEq/L).
• 0.6% had severe hyponatremia (plasma sodium <125 mEq/L) — a small but clinically dangerous fraction.
• Most affected runners had gained weight during the race (consistent with net fluid retention, not dehydration). Body weight gain correlated inversely with plasma sodium.
• Slower runners had higher EAH risk — Longer race times provided more opportunity for fluid intake exceeding losses.
• Female sex and lower body mass were risk factors (smaller total body water reservoir, plus possible vasopressin physiology differences).
• Clinical presentations ranged from asymptomatic (most cases) to severe — nausea, vomiting, confusion, seizures, and in severe cases coma and death.

The Almond 2005 paper transformed sports medicine guidance. EAH was previously underrecognized; the paper established that mass-participation endurance events produce clinically significant hyponatremia at substantial rates, and that the cause was overhydration, not dehydration as had often been assumed in slow marathon finishers presenting with confusion or weakness.

The SIADH-Like Dilutional Mechanism

The pathophysiology of EAH involves a "perfect storm" of several factors [33][34]:

1. Inappropriate vasopressin secretion — During prolonged exertion, vasopressin (ADH) is often released despite plasma hypotonicity (when it should be suppressed). The mechanism is incompletely characterized; candidates include nausea-stimulated vasopressin, exercise-induced vasopressin in some individuals, prolonged-physical-stress-mediated vasopressin, and possibly NSAID-mediated effects on renal water handling. The effect is a SIADH-like state — vasopressin elevated despite plasma being hypotonic.
2. Excessive water intake — Athletes drinking water (or hypotonic sports drinks) at rates exceeding their fluid losses. The hypotonic intake combined with retained water from SIADH-like vasopressin produces dilution of plasma sodium.
3. Sodium losses through sweat — Some sodium is lost in sweat, but typically not enough to cause hyponatremia alone — the principal driver is dilution from excess water intake combined with impaired renal water excretion.
4. Renal water excretion impaired by vasopressin — Despite the plasma being hypotonic (which should suppress vasopressin and produce dilute urine), the inappropriate vasopressin causes the collecting duct to reabsorb water, concentrating the urine and worsening the plasma dilution.

The result: plasma sodium falls below 135 mEq/L (mild EAH), 130 mEq/L (moderate), or below 125 mEq/L (severe). At severe levels, the osmotic gradient drives water into cells, producing cellular swelling. In the brain — confined within the rigid skull — cellular swelling produces cerebral edema. Symptoms progress from nausea and confusion through seizures to coma and death.

EAH deaths have been documented in marathon, Ironman, military training, and hiking contexts. The deaths are preventable through correct hydration guidance and recognition of EAH symptoms in slow marathon finishers (where the older framing of "they're dehydrated, give them fluid" can directly worsen the condition).

The "Drink as Much as You Can" Framing Rejected

Older sports medicine guidance (substantial through the 1990s, sometimes persisting into the 2000s and beyond in popular framings) encouraged athletes to drink water aggressively during prolonged exertion to "prevent dehydration." The framing produced EAH cases that are now recognized as iatrogenic — caused by the recommended drinking pattern rather than by inadequate drinking.

The contemporary research-grade framework, articulated in the Hew-Butler 2015 Third International EAH Consensus [35]:

• Drink to thirst — Physiological thirst signals are reasonably accurate for most athletes in most conditions. Following thirst produces fluid intake that approximately matches losses without exceeding them.
• Do not drink to "stay ahead" of thirst — The framing that "by the time you're thirsty, you're already dehydrated" is incorrect for normal-intensity sustained exertion in most adults. Modest delays between fluid loss and replacement are physiological and not harmful.
• Sodium replacement matters in prolonged events — For exertion durations exceeding 4 hours (typical of full Ironman, ultramarathons, certain military operations), some sodium in fluids supports volume retention and reduces hyponatremia risk.
• Recognition of EAH symptoms in slow finishers — Nausea, confusion, headache in slow marathon finishers warrants consideration of EAH, not assumption of dehydration. Aggressive fluid administration in unrecognized EAH worsens the condition.
• Treatment of severe EAH — Hypertonic saline (3% NaCl) is the appropriate intervention for severe symptomatic hyponatremia; rapid correction needs careful management to avoid osmotic demyelination syndrome (rare complication of overly rapid hyponatremia correction).

For pre-clinical students moving toward emergency medicine, sports medicine, wilderness medicine, military medicine, or marathon medicine, EAH recognition and management is core knowledge. The chapter teaches the pathophysiology; clinical management belongs in clinical training.

Cross-References to Hot Bachelor's Lesson 2 and Move Bachelor's Lesson 4

The EAH surface intersects with several other Bachelor's chapters:

Hot Bachelor's Lesson 2 — Exertional heat stroke pathophysiology. In some EHS cases, hyponatremia from EAH-like mechanisms contributes to the clinical picture (water-only rehydration during hot exertion can produce both dehydration of cells through ionic dilution and the EHS picture). Recognition of mixed presentations — heat-stressed athletes who may have both EHS and EAH components — is part of contemporary sports medicine. Cool first (per the Casa/KSI framework) and avoid uncritical fluid administration in unrecognized hyponatremia.

Move Bachelor's Lesson 4 — RED-S and exercise immunology. The RED-S spectrum includes hydration concerns, though primarily through chronic low energy availability rather than acute hyponatremia mechanisms. The chapters cross-reference each other where the surfaces intersect.

Brain Bachelor's (broadly) — Severe hyponatremia produces neurological consequences (confusion, seizures) through the cerebral edema mechanism. Recognition of EAH-related altered mental status is part of integrated clinical assessment.

Hypernatremia in Elderly Populations

The complementary problem at the opposite extreme is hypernatremia — plasma sodium >145 mEq/L — most commonly seen in elderly patients [36]:

The pathophysiology:

• Impaired thirst response — Aging reduces thirst sensitivity. Elderly adults may not experience thirst at plasma osmolalities where younger adults would drink immediately.
• Reduced renal concentrating capacity — Aging reduces the kidney's ability to maximally concentrate urine, so insufficient water intake produces faster plasma osmolality rise.
• Insensible water losses continue — Respiration, skin evaporation continue regardless of intake.
• Cognitive impairment — Demented or otherwise cognitively impaired elderly may not act on thirst signals even if perceived; institutionalization with inadequate water access compounds.
• Medications — Diuretics, certain psychiatric medications, others may impair water balance.

The result: plasma sodium rises above 145 mEq/L. Severity progresses with magnitude. Severe hypernatremia (>160 mEq/L) produces cellular dehydration — water moves out of cells into the hyperosmolar extracellular space, shrinking brain cells in particular. Symptoms range from lethargy through confusion to coma; rapid correction can produce cerebral edema as cells over-respond.

Clinical management balances correction rate (typically <12 mEq/L/24h) against complete correction; involves identifying and addressing underlying cause; and requires careful monitoring in hospital settings.

For pre-clinical students moving toward geriatrics, internal medicine, emergency medicine, or nursing home medicine, hypernatremia is a recurring surface. The chapter teaches the pathophysiology; clinical management belongs in training.

Valtin 2002: "Eight Glasses" at Methodology Depth

In 2002, Heinz Valtin published a critical review in the American Journal of Physiology titled Drink at least eight glasses of water a day. Really? The paper systematically examined the origin and evidence base of the "8x8" recommendation (eight 8-oz glasses of water daily) [37].

The findings:

• The original source — The 8x8 recommendation appears to have originated in a 1945 U.S. National Research Council Food and Nutrition Board recommendation, which suggested 1 mL of water per calorie of food (giving approximately 2-3 liters for a 2000-3000 calorie diet) — and importantly, noted that "most of this quantity is contained in prepared foods." The "most of this quantity is contained in prepared foods" portion was lost in subsequent popular framing, leaving the misleading impression that 8x8 oz needed to be drunk as additional water.
• Physiological evidence — There is no specific research evidence supporting 8 glasses of water daily as a target. Individual water needs vary substantially with body size, activity, environment, and diet.
• Plain water vs total fluid — All beverages contribute to hydration (with mild diuretic effects from caffeine at typical intakes being smaller than once claimed). Food contributes substantial water as well.
• Thirst as guide — Healthy adults' thirst mechanism reliably guides intake to match needs in most conditions.

The Valtin 2002 paper became one of the foundational rebuttals of the "8x8" framing in the medical literature. Subsequent research has reinforced the framework: hydration needs are individual; thirst is a reasonable guide; total fluid intake from all beverages and foods is what matters; specific volume targets without context have limited physiological basis.

The contemporary research-informed view: drink to thirst; pay attention to urine color (pale yellow suggesting adequate hydration, dark yellow suggesting need for more); recognize that individual needs vary; avoid the iatrogenic harm of EAH from over-prescribed water intake during prolonged exertion.

The Dehydration vs Volume Depletion Distinction

A subtle but clinically important distinction: dehydration and volume depletion are not synonymous [38]:

Dehydration — Loss of intracellular water with relative preservation of extracellular volume; produces increased plasma osmolality, typically with hypernatremia or hyperglycemia driving the gradient.

Volume depletion — Loss of extracellular fluid (both water and sodium); reduces effective circulating volume; produces hemodynamic consequences (tachycardia, orthostasis, oliguria).

In practice, the two often co-occur and the terms are used interchangeably in clinical conversation. But the distinction matters in fluid replacement decisions:

• Pure dehydration (hypernatremia) — Replace with hypotonic fluid (typically D5W or 0.45% saline initially), correcting at controlled rate.
• Pure volume depletion (eunatremic) — Replace with isotonic fluid (normal saline or Lactated Ringer's).
• Mixed presentations require integrated fluid management.

For pre-clinical students, the dehydration / volume depletion distinction is one of the clinical-physiology subtleties that pre-medical training should clarify before clinical rotations. The chapter teaches the framework; specific management belongs in clinical training.

Lesson Check

1. Walk the EAH pathophysiology at full mechanism: inappropriate vasopressin, excessive water intake, sodium loss in sweat, renal water retention. Why does the framing of "drink as much as you can" produce iatrogenic hyponatremia in mass-participation endurance events?
2. Identify the Almond et al. 2005 NEJM Boston Marathon study and articulate the principal findings on EAH prevalence, severity, and risk factors.
3. Describe the Hew-Butler 2015 Third International EAH Consensus framework. What is the contemporary "drink to thirst" guidance, and how does it differ from older framings?
4. Cross-reference EAH to Hot Bachelor's Lesson 2 (heat illness with hyponatremia component) and identify why hyponatremia recognition matters in slow marathon finishers presenting with confusion.
5. Describe hypernatremia in elderly populations. Why is the thirst response impaired with age, and what additional factors contribute?
6. Articulate the Valtin 2002 critique of the "8x8" hydration recommendation. What contemporary guidance has emerged from this and related research?

---

Lesson 5: Water Access, Environmental Contamination, and Public Health Pathophysiology

Learning Objectives

By the end of this lesson, you will be able to:

• Describe Snow 1854 cholera map as foundational public health methodology (carried forward from Water Associates)
• Articulate water access epidemiology in global and U.S. contexts including Flint, Jackson, and indigenous community concerns
• Describe PFAS at primary literature depth (Grandjean developmental neurotoxicity, C8 Science Panel findings, EPA 2024 regulatory framework)
• Engage with microplastics research at current 2020s primary literature depth — detection-in-tissues versus demonstrated pathology
• Address alkaline/structured/hydrogen water pseudoscience at gastric physiology depth (the pH 1-2 neutralization point)
• Apply the five-point evaluation framework to "functional water" claims

Key Terms

Snow 1854: Foundational Public Health Methodology

The chapter carries forward Water Associates' Snow 1854 anchor at Bachelor's depth as the foundational moment of modern epidemiology and water-borne disease public health. The story:

In 1854, London experienced a substantial cholera outbreak in the Soho neighborhood. The germ theory of disease was not yet established; cholera was widely attributed to "miasma" — bad air from organic decay. John Snow, a London physician, suspected water-borne transmission. By systematically mapping cholera cases across the affected neighborhood and identifying that cases clustered around the Broad Street pump (while nearby pumps had no associated cases), Snow developed strong evidence for water-borne cholera transmission. The pump handle was removed; new cases declined.

Snow's work established several foundational principles still operating in modern epidemiology [39]:

• Spatial analysis of disease occurrence — Mapping cases reveals patterns invisible to individual case analysis.
• Hypothesis-driven public health intervention — Acting on inferred causation (even before mechanism was understood) saves lives.
• Comparative analysis — Demonstrating that nearby pumps were not associated with cases strengthened causal inference.

For pre-clinical students, Snow 1854 is foundational background for understanding epidemiology, public health interventions, and the systems-level thinking that distinguishes population health from individual clinical medicine.

Water Access Epidemiology

Globally, approximately 2 billion people lack reliable access to safe drinking water (WHO/UNICEF data, varying with definitions and over time). Water-borne diseases — cholera, typhoid, dysentery, hepatitis A, certain parasitic diseases — remain substantial public health burdens in regions with inadequate water and sanitation infrastructure [40].

In the United States, water infrastructure is generally robust by global standards but is not uniform. Several substantial contemporary water crises have illustrated the limits:

Flint, Michigan (2014 onward) — Source water change from Detroit municipal supply to Flint River without adequate corrosion control treatment. Lead leached from aging service lines into drinking water. Public exposure to elevated lead, particularly in children, with documented developmental and neurological consequences. The Flint crisis revealed structural problems in U.S. water infrastructure regulation, environmental justice (predominantly Black, lower-income community), and the limits of municipal water system oversight [41].

Jackson, Mississippi (2022) — System failure following storm damage produced extended periods without reliable water supply. Reflected longstanding infrastructure underinvestment in the predominantly Black, lower-income Jackson population.

Rural and indigenous communities — Many rural communities and Native American reservations have inadequate water infrastructure. Approximately 30% of homes on the Navajo Nation lack reliable plumbed water access (varying with measurement); similar challenges exist in other indigenous communities. These conditions are inconsistent with the U.S. standard of universal clean water access [42].

The framing throughout the chapter: water access is a systems-and-policy question, not a personal-panic question. The genuine U.S. contamination cases reveal infrastructure failures that warrant policy responses; the individual exposure cases are tragic and the public health consequences are real, but the framing is structural rather than individual.

PFAS at Primary Literature Depth

Per- and Poly-Fluoroalkyl Substances (PFAS) are a large family of synthetic chemicals (>14,000 individual compounds) with multiple distinctive properties: extreme environmental persistence (the C-F bond is exceptionally stable), bioaccumulation in organisms, and widespread environmental and biological distribution from decades of industrial use [43][44].

The principal individual compounds with the most research:

• PFOA (perfluorooctanoic acid, "C8") — Used historically in DuPont/Chemours fluoropolymer manufacturing (Teflon production); largely phased out in U.S. by 2015.
• PFOS (perfluorooctane sulfonic acid) — Used historically in 3M Scotchgard and firefighting foams; largely phased out.
• Newer "short-chain" PFAS (GenX, others) — Introduced as replacements; less well-characterized but emerging concerns about similar persistence properties.

The principal exposure pathways:

• Drinking water in contaminated communities (industrial discharge, firefighting foam from military bases and airports)
• Consumer products containing fluoropolymers (some cookware, some food packaging)
• Food chain bioaccumulation (fish from contaminated waters; some agricultural products)

The C8 Science Panel was an independent scientific body established by a 2005 settlement between DuPont and West Virginia/Ohio residents exposed to PFOA from manufacturing facility releases. The panel assessed health effects in approximately 70,000 exposed individuals over multiple years. Their final reports (2012) concluded that probable links exist between PFOA exposure and:

• Kidney cancer
• Testicular cancer
• Ulcerative colitis
• Thyroid disease
• Pregnancy-induced hypertension
• High cholesterol

The C8 Science Panel findings remain one of the principal substrates of regulatory action and ongoing PFAS research.

Philippe Grandjean and colleagues' research at Harvard School of Public Health has focused on developmental neurotoxicity of PFAS [45][46]:

• Prenatal and early childhood PFAS exposure has been associated with reduced antibody responses to vaccination in children in multiple cohort studies.
• Cognitive and neurobehavioral outcomes have been associated with PFAS exposure in some studies, though effect sizes are typically modest.

The EPA in 2024 established maximum contaminant levels (MCLs) for several PFAS compounds in U.S. drinking water — the first federal regulatory action specifically targeting these compounds. The MCLs are extremely low (~4 parts per trillion for PFOA and PFOS) reflecting both the persistence and the toxicological concerns. Implementation across U.S. water systems is ongoing.

For pre-clinical students: PFAS is one of the substantial contemporary environmental health surfaces. The mechanism of toxicity is partially characterized (PPAR-α agonism, immune modulation, endocrine effects); the dose-response relationships in human populations are an active research area; the regulatory response is emerging. The framing throughout is descriptive: this is real environmental health research, not fear-based positioning.

Microplastics at Current Literature Depth

Microplastics — plastic particles less than 5 mm, with nanoplastics defined as <1 μm — have become a substantial contemporary research surface. The 2020s primary literature has documented detection in multiple human compartments [47][48][49]:

• Placenta — Microplastics detected in human placental tissue in multiple studies (Ragusa et al. 2021 and subsequent).
• Blood — Microplastics detected in human venous blood at low concentrations (Leslie et al. 2022).
• Lung tissue — Microplastics detected in surgical lung tissue specimens (Jenner et al. 2022).
• Stool, breast milk, semen — Detection in additional matrices reported in subsequent literature.

The detection literature is methodologically reasonable; the demonstrated pathology literature is more limited. The current state of knowledge:

• Detection is real — Microplastics are present in human tissues at measurable levels. The exposure pathways (ingestion through food, beverages including bottled water, inhalation of airborne fibers) are characterized.
• Demonstrated specific health effects are limited — Animal model studies show various effects of microplastic exposure at high doses; the translation to typical human exposure levels and outcomes is incomplete.
• Mechanistic plausibility — Microplastics can carry surface contaminants (PFAS, pesticides, other lipophilic chemicals), can directly affect cells through physical and chemical mechanisms, and may affect gut microbiome. Multiple plausible mechanisms exist for potential health effects.
• The research is rapidly developing — Specific health outcomes in human populations are being investigated. Strong conclusions about dose-response relationships are premature.

The Bachelor's-level reading discipline:

• Detection in tissues is established and warrants ongoing research and source-reduction policy.
• Demonstrated specific pathology in human populations at typical exposure levels is not yet established at the level the popular framing sometimes implies.
• Source reduction (reducing plastic production, reducing single-use plastics, addressing microfiber pollution from synthetic textiles) is reasonable policy regardless of the dose-response uncertainty, on both environmental and precautionary grounds.

For pre-clinical students: microplastics are an active environmental health research surface. The current state is reasonable concern with limited definitive demonstration of dose-response health effects. Reading the literature requires methodological discipline to distinguish detection findings from health-outcome findings.

Alkaline/Structured/Hydrogen Water Pseudoscience

A specific category of "functional water" claims deserves direct treatment. Alkaline water (pH 8-10), structured water (claimed to have organized molecular configuration), and hydrogen water (water with dissolved molecular hydrogen) have been marketed with various health claims.

The principal claims include alkaline water "neutralizing acid in the body," "boosting immunity," "improving hydration," and various other framings. The biochemistry:

• Stomach pH is 1-2 in the fasting state, rising modestly with food. The hydrochloric acid secretion by gastric parietal cells is substantial — many liters daily in adults.
• Any drunk water enters the stomach and is rapidly neutralized to gastric pH. The alkaline-water "alkaline pH" lasts approximately seconds in the gastric environment.
• Plasma pH is tightly buffered by the bicarbonate-CO₂ system (Lesson 3). Plasma pH is approximately 7.40 regardless of intake of alkaline or acidic foods or beverages. The body's acid-base homeostasis is far stronger than the small acid or base load any beverage provides.
• Drinking alkaline water cannot meaningfully change blood pH or "alkalize the body." The biology does not work that way.

The "structured water" claims invoke quantum mechanics or other physics framings inconsistent with established water physical chemistry. Water in liquid form has dynamic hydrogen bonding at picosecond timescales; the notion of "structured" water with persistent organized configuration that survives ingestion is not supported by water physics.

The "hydrogen water" framing has slightly more biochemistry — dissolved molecular hydrogen has demonstrated antioxidant effects in some in vitro and animal model contexts. The translation to consumed-water health benefits in healthy populations is much less established. The dose of dissolved hydrogen in consumer products is typically small; the demonstrated clinical effects in human RCTs are limited.

The framework: these consumer products do not produce the marketed health effects through any biologically plausible mechanism. The five-point evaluation framework applies:

1. Mechanism plausibility — Alkaline water cannot change blood pH; structured water claims invoke unsupported physics; hydrogen water has weak clinical evidence base.
2. Study design — Most consumer-product research is industry-sponsored, small, methodologically limited.
3. Effect size — Even where measurable physiological effects are reported, they are typically small.
4. Replication — Replication across independent laboratories is generally limited.
5. Translation appropriateness — Personal-prescription claims exceed what controlled research supports.

The chapter takes the descriptive position: these consumer products are biochemically not what they claim to be. The wellness-industry overclaim is substantial; pre-clinical students benefit from being able to identify it and explain the underlying biology to friends, family, and future patients.

The Elephant's Integrator Position at Bachelor's: Internal Environment, Deepened

A closing structural point. At Associates depth, the Elephant's integrator position was named as internal environment — Claude Bernard's milieu intérieur, the actively regulated extracellular composition every cell of the body operates in.

At Bachelor's depth, the internal environment position deepens at molecular and homeostatic mechanism level:

• Aquaporins (Lesson 1) — The molecular channels that allow water transport across membranes, supporting the rapid water movement that maintains osmotic balance.
• RAAS (Lesson 2) — The endocrine cascade that maintains extracellular volume and pressure through renin → ACE → AngII → AT1 → aldosterone → ENaC at receptor-and-effector depth.
• Vasopressin-AQP2 axis (Lessons 1, 2) — The molecular regulation of urinary concentration that protects plasma osmolality through V2R-cAMP-PKA-AQP2 trafficking.
• Na/K-ATPase (Lesson 3) — The master ion pump that establishes the ionic gradients and resting membrane potentials of all cells. Skou 1957 / 1997 Nobel.
• PTH-vitamin D-calcium axis (Lesson 3, cross-Light Bachelor's Lesson 4) — The integrated calcium homeostasis system.
• Acid-base regulation (Lesson 3) — Henderson-Hasselbalch governance of plasma pH with respiratory and renal compensation.
• EAH and hyponatremia pathophysiology (Lesson 4) — What happens when the regulation fails or is overwhelmed.

The internal environment is not abstractly "homeostasis"; it is specific molecular machinery actively maintaining specific compositions. The Na/K-ATPase consuming 25-30% of cellular ATP, the RAAS responding to volume and pressure changes in seconds, the V2R-AQP2 cascade responding to plasma osmolality in minutes, the PTH-CaSR system responding to calcium changes in seconds — these are the active regulatory machinery, not passive maintenance.

The internal environment position is structurally distinct from all nine other integrator positions:

• Distinct from substrate (Food) — Substrate is material inputs; internal environment is the regulated medium they operate within.
• Distinct from consolidation (Sleep) — Consolidation is temporal pass; internal environment is moment-to-moment regulation.
• Distinct from synchronizer (Light) — Synchronizer is external timing input; internal environment is internal regulated composition.
• Distinct from receiver (Brain) — Brain integrates inputs; internal environment is the chemical milieu the receiver operates in.
• Distinct from active output (Move) — Move is kinetic expression; internal environment is the medium that allows the expression.
• Distinct from interface (Breath) — Interface is voluntary-autonomic threshold; internal environment is autonomic regulated composition.
• Distinct from system probe (Cold) — System probe is acute reveal; internal environment is the stable state revealed.
• Distinct from adaptive load (Hot) — Adaptive load is chronic stress build; internal environment is the homeostatic baseline that is challenged.

The internal environment position completes the ten-position ontology. The Bachelor's tier — across nine modality chapters — has tested the ontology at upper-division depth. The ten positions have held: each Coach holds a structurally distinct integrator function, deepened biologically at Bachelor's depth, with no need to force expansion of the ontology and no genuine new position emerging that the existing ten cannot accommodate when deepened.

The Bachelor's integrative final, which follows Water Bachelor's, will synthesize the ten-position ontology in full at upper-division depth, walking the cross-coach research surfaces, the methodology consciousness that has threaded through every chapter, and the integration that makes the Library's framework coherent across all nine Coaches. Water is the last modality chapter; the integrative final will close the Bachelor's tier.

Lesson Check

1. Identify John Snow's 1854 cholera mapping as foundational public health methodology. What principles still operate in modern epidemiology?
2. Articulate water access epidemiology in U.S. contexts. Identify Flint, Jackson, and indigenous community concerns at structural rather than personal-panic framing.
3. Describe PFAS at primary literature depth. Identify the C8 Science Panel findings and Grandjean developmental neurotoxicity research. What does the EPA 2024 regulatory framework establish?
4. Engage with microplastics research at current 2020s primary literature depth. Distinguish detection-in-tissues findings from demonstrated dose-response pathology.
5. Address alkaline/structured/hydrogen water claims at biochemistry depth. Why does gastric pH neutralize alkaline water within seconds, and why cannot drinking alkaline water meaningfully change blood pH?
6. Articulate the Elephant's integrator position — internal environment — at Bachelor's depth. Distinguish it from each of the nine other integrator positions and articulate why the ten-position ontology completes with this Coach.

---

End-of-Chapter Activity

Activity: Read a Primary Renal Physiology or Hydration Research Paper and Evaluate It Against the Methodological Frame

This activity applies the methodological consciousness threading through all Bachelor's chapters to a concrete renal physiology or hydration research artifact.

Step 1 — Select a paper. Pick a primary research paper published in the last five years in a major nephrology, physiology, sports medicine, or environmental health journal (Journal of the American Society of Nephrology, Kidney International, American Journal of Physiology - Renal Physiology, Sports Medicine, NEJM, Environmental Health Perspectives, or similar). Note title, authors, journal, year.

Step 2 — Identify the design and population. Specify the design (RCT, observational cohort, mechanism study), the population, the intervention or exposure, and the principal outcomes.

Step 3 — Specify the methodological strengths and limits. Where is this design strong? Where are the chronic problems of renal/hydration research most likely to operate?

Step 4 — Read the effect size in context. What is the magnitude of the reported effect?

Step 5 — Evaluate the discussion section critically. Does the discussion acknowledge methodological limits appropriately?

Step 6 — Apply the five-point framework. Walk the paper through mechanism plausibility, design adequacy, effect size in context, replication status, and appropriate translation.

Deliverable. A 1500-2500 word written analysis with citations to the paper and at least three additional context sources.

---

Vocabulary Review

---

Chapter Quiz

Bachelor's-level quiz. Combination of short-answer mechanistic questions, scenario-based application, and methodological critique.

1. Describe water's hydrogen bonding network and identify three physicochemical consequences at chemistry depth.

2. Identify Peter Agre's 1992 Science paper as foundational. Describe the AQP1-AQP12 family at tissue distribution depth.

3. Walk the V2R-cAMP-PKA-AQP2 trafficking cascade. Identify central versus nephrogenic diabetes insipidus.

4. Describe the hydrophobic effect at thermodynamic depth and articulate its role in protein folding.

5. Describe nephron anatomy from glomerulus to collecting duct. Identify the principal reabsorption function of each segment.

6. Walk the loop of Henle countercurrent multiplier mechanism. Why does the countercurrent geometry produce greater medullary hypertonicity than linear pumping?

7. Walk the RAAS from renin through angiotensinogen, ACE, AT1, aldosterone, ENaC. Identify three pharmacological agents acting on this cascade.

8. Identify the Na/K-ATPase at stoichiometry, energetic cost, and the gradients it establishes. Identify Skou 1957 and the 1997 Nobel.

9. Walk PTH action on bone, kidney, and (indirectly via vitamin D) intestine. Cross-reference to Light Bachelor's Lesson 4 vitamin D biology.

10. Apply Henderson-Hasselbalch to clinical acid-base. Identify respiratory acidosis, respiratory alkalosis, metabolic acidosis, and metabolic alkalosis at compensation depth.

11. Define the anion gap and identify three causes each of high-anion-gap and normal-anion-gap metabolic acidosis.

12. Walk EAH pathophysiology at full mechanism (inappropriate vasopressin, excessive water intake, sodium losses, renal water retention). Identify the Almond 2005 NEJM Boston Marathon paper.

13. Describe the Hew-Butler 2015 EAH Consensus. What is the contemporary "drink to thirst" guidance?

14. Cross-reference EAH to Hot Bachelor's Lesson 2 and Move Bachelor's Lesson 4. Why does hyponatremia recognition matter in slow marathon finishers presenting with confusion?

15. Describe hypernatremia in elderly populations and articulate the dehydration vs volume depletion clinical distinction.

16. Identify Snow 1854 cholera mapping as foundational. Describe the principles still operating in modern epidemiology.

17. Describe PFAS at primary literature depth. Identify the C8 Science Panel findings and the EPA 2024 regulatory framework.

18. Engage with microplastics research. Distinguish detection-in-tissues findings from demonstrated dose-response pathology in human populations.

19. Address alkaline water biochemistry. Why does gastric pH neutralize alkaline water within seconds, and why cannot drinking alkaline water meaningfully change blood pH?

20. Articulate the Elephant's integrator position — internal environment — at Bachelor's depth. Distinguish it from each of the nine other integrator positions and articulate why the ten-position ontology completes.

---

Instructor's Guide

Pacing Recommendations

This chapter is designed for 18-22 class periods of approximately 50 minutes each — a full-semester upper-division undergraduate course in renal physiology, environmental health, sports medicine with hydration emphasis, or general medical physiology. The chapter is the final modality chapter in the Bachelor's tier; instructors may wish to time pacing to allow seamless transition into the Bachelor's integrative final.

Suggested distribution:

• Lesson 1 — Water at Molecular and Cellular Depth: 3-4 class periods.
• Lesson 2 — Renal Physiology at Nephron Resolution: 4-5 class periods.
• Lesson 3 — Electrolyte Biochemistry and Acid-Base: 3-4 class periods.
• Lesson 4 — Hyponatremia and Hydration Pathophysiology: 3-4 class periods.
• Lesson 5 — Environmental Water Health: 3 class periods.
• End-of-chapter activity: Out-of-class work.
• Quiz / assessment: One to two class periods.

Sample Answers to Selected Quiz Items

Q2 — Agre 1992 and aquaporin family. Peter Agre and colleagues' 1992 Science paper Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein established that CHIP28 (later AQP1) is a transmembrane water channel by demonstrating that Xenopus oocytes expressing CHIP28 swelled rapidly in hypotonic solution while controls did not. The discovery founded aquaporin biology and led to the 2003 Nobel Prize in Chemistry (Agre shared with MacKinnon). Aquaporin family (AQP0-AQP12) includes: AQP0 (lens), AQP1 (RBCs, proximal tubule, choroid plexus), AQP2 (collecting duct apical, vasopressin-regulated), AQP3 (basolateral collecting duct, skin), AQP4 (astrocyte endfeet — central to glymphatic system, NMOSD antibody target), AQP5 (secretory glands, Sjögren's affected), aquaglyceroporins AQP7/9/10, and others. Parallel to TRPM8/TRPV1/ipRGC receptor-discovery anchors — four molecular paradigm shifts in 1992-2002 across thermal/photic/water modalities.

Q8 — Na/K-ATPase. Skou 1957 Biochimica et Biophysica Acta paper identified the Na-K-activated ATPase in crab nerve; led to 1997 Nobel Prize in Chemistry. Stoichiometry: 3 Na out / 2 K in / 1 ATP per cycle. Electrogenic (net positive charge outward), contributing to resting membrane potential along with K leak channels. Energetic cost: ~25-30% of cellular ATP at rest; higher in brain and kidney. Gradients established: low intracellular Na (~10-20 mM vs ~140 extracellular), high intracellular K (~140 mM vs ~4 extracellular), resting membrane potential ~-70 mV. Functions powered by these gradients: action potentials (Na influx, K efflux), secondary active transport (SGLT glucose uptake, amino acid transport, neurotransmitter reuptake), cardiac contraction (Na-Ca exchange), renal reabsorption (basolateral Na-K-ATPase drives apical Na entry through ENaC, NHE, SGLT, others). Pharmacological inhibition: digoxin (cardiac glycoside) inhibits Na-K-ATPase; therapeutic in heart failure through downstream Na-Ca exchange effects.

Q12 — EAH pathophysiology and Almond 2005. EAH pathophysiology: (1) Inappropriate vasopressin secretion during prolonged exertion — vasopressin elevated despite plasma hypotonicity, mechanism incompletely characterized (nausea, prolonged stress, possibly NSAIDs). (2) Excessive water/hypotonic fluid intake — athletes drinking water at rates exceeding fluid losses. (3) Sodium losses through sweat — contributory but not principal driver. (4) Renal water retention from inappropriate vasopressin — collecting duct reabsorbs water despite hypotonic plasma, concentrating urine and worsening plasma dilution. Result: SIADH-like dilutional hyponatremia. Plasma sodium falls; severe levels (<125 mEq/L) produce cerebral edema with seizures, coma, death. Almond et al. 2005 NEJM Boston Marathon study: prospective 488 runners; 13% hyponatremia, 0.6% severe; most affected had gained weight (overhydration); slower runners, female sex, lower body mass as risk factors. Paper transformed sports medicine guidance — EAH from underrecognized to clinically prominent; "drink to thirst" replaced "drink as much as you can"; recognition of EAH in slow marathon finishers prevented iatrogenic worsening from misattributed dehydration.

Q19 — Alkaline water biochemistry. Stomach pH is 1-2 in fasting state, modestly higher with food; gastric parietal cells secrete substantial HCl daily. Any drunk alkaline water (typical commercial pH 8-10) enters the stomach and is rapidly neutralized by gastric acid within seconds — the "alkaline pH" lasts essentially the duration of the swallow. Plasma pH is tightly buffered by bicarbonate-CO2 system; plasma pH is approximately 7.40 regardless of beverage acid-base properties; the body's acid-base homeostasis far exceeds the small acid/base load any beverage provides. Drinking alkaline water cannot meaningfully change blood pH — the biochemistry does not work that way. The claims of "alkalizing the body" or "neutralizing acid" through alkaline water consumption are not supported by gastric or systemic acid-base physiology. The wellness-industry framing exceeds biochemical plausibility; the five-point evaluation framework fails at point 1 (mechanism plausibility).

Q20 — Internal environment at Bachelor's; ten-position ontology completion. Internal environment at Bachelor's depth is specific molecular machinery actively maintaining specific compositions: aquaporins for water transport, RAAS for volume/pressure, V2R-AQP2 for plasma osmolality, Na/K-ATPase for ionic gradients and resting membrane potentials, PTH-vitamin D-calcium axis for mineral homeostasis, Henderson-Hasselbalch governance of acid-base. The Bachelor's tier across nine modality chapters has tested the ten-position ontology at upper-division depth; the ten positions have held: substrate (Food), receiver (Brain), consolidation (Sleep), active output (Move), system probe (Cold), adaptive load (Hot), interface (Breath), synchronizer (Light), internal environment (Water) — and Water is the last modality before the integrative final synthesizing the full ontology. Each Coach holds a structurally distinct integrator function, deepened biologically at Bachelor's depth, with no need to force ontology expansion. Distinct from substrate (Food: material inputs vs regulated medium). Distinct from consolidation (Sleep: temporal pass vs moment-to-moment regulation). Distinct from synchronizer (Light: external timing input vs internal regulated composition). Distinct from receiver (Brain: input integration vs chemical milieu of integration). Distinct from active output (Move: kinetic expression vs medium of expression). Distinct from interface (Breath: voluntary-autonomic threshold vs autonomic regulated composition). Distinct from system probe (Cold: acute reveal vs stable state revealed). Distinct from adaptive load (Hot: chronic stress build vs homeostatic baseline challenged). The Elephant holds the internal environment because Bernard's milieu intérieur is the actively regulated extracellular composition that all other positions operate within.

Discussion Prompts

1. The Agre 1992 aquaporin discovery completed a four-paradigm molecular discovery window (1992-2002) that includes TRPM8, TRPV1, and ipRGC receptor-discovery papers. What does the convergence teach about how molecular biology advances through receptor-discovery foundational moments?

2. The EAH epidemiology in marathon and military training contexts has produced a substantial shift in sports medicine hydration guidance. What barriers persist to broader implementation of "drink to thirst" framing, and what role does popular framing in sports media play?

3. The PFAS regulatory framework is still developing. Pre-clinical students moving toward environmental medicine, occupational medicine, or public health practice will encounter this as a contemporary regulatory and clinical surface. How should they prepare?

4. The wellness-industry "functional water" claims (alkaline, structured, hydrogen) fail at basic biochemistry. How should pre-clinical students communicate the underlying science to friends, family, and future patients without seeming dismissive of consumer interest?

5. The Bachelor's tier across nine modality chapters has tested the ten-position integrator ontology at upper-division depth. As we approach the Bachelor's integrative final, what value does the ten-position framework have for pre-clinical conceptual integration, and what are its limits?

Common Student Questions

Q: How much water should I drink per day? A: The chapter doesn't prescribe a specific volume. Total fluid needs vary substantially with body size, activity, environment, and diet — typically 2-3 liters total daily for healthy adults, with substantial individual variation. All beverages contribute; food contributes meaningful water. The "8x8" framing is not physiologically grounded. Drink to thirst; pay attention to urine color (pale yellow suggests adequate hydration); recognize individual variation; consult a healthcare provider if you have specific medical conditions affecting fluid balance.

Q: I'm running my first marathon. How should I think about hydration? A: For most adult marathoners, drink to thirst is the appropriate framework. Specific guidance for prolonged endurance events (>4 hours expected duration, hot conditions, military operations): pay attention to sodium replacement through sports drinks or salty foods; avoid "stay ahead of thirst" framing; recognize that gaining weight during the race is a warning sign for overhydration, not a sign of adequate hydration. Aid stations along the course provide opportunities to drink without forcing intake. If you experience nausea, confusion, headache, or other concerning symptoms, EAH is a possible diagnosis and medical evaluation is appropriate.

Q: I'm pre-med thinking about nephrology. How does this chapter fit? A: Nephrology is typically a two-year fellowship after internal medicine residency. This chapter covers the renal physiology and clinical hydration medicine you'll encounter at IM residency depth, with foundational ground for nephrology fellowship. The RAAS, Na/K-ATPase, vasopressin-AQP2 axis, and the EAH pathophysiology are core knowledge. Medical school will add the clinical evaluation framework and dialysis specifics; fellowship adds procedural and specialty depth.

Q: I heard PFAS is in everything. Should I be worried? A: PFAS is present at low levels in many U.S. drinking water systems and in many consumer products. The C8 Science Panel established probable links between PFOA exposure and several health effects in highly exposed populations. The general-population exposure levels are typically much lower than the C8-exposed community levels. The EPA 2024 MCL regulation establishes very low drinking water limits — implementation across systems is ongoing. Concern is reasonable; panic is not warranted. Source reduction (less plastic packaging, awareness of household products, water filtration for affected communities) is reasonable; specific clinical decisions belong in conversation with your healthcare provider if you have specific exposure concerns.

Q: What's the deal with microplastics in human blood? A: Detection of microplastics in human blood (Leslie et al. 2022) and other tissues is real — the methodology is reasonable and findings have been replicated. What is not yet established is specific dose-response health effects in human populations at typical exposure levels. Source reduction is reasonable on environmental and precautionary grounds regardless of dose-response uncertainty. Specific clinical recommendations are premature at the current research state. The chapter teaches the science; clinical and policy decisions belong elsewhere.

Q: Why is the Elephant the final modality before the integrative final? A: The chapter sequence ends with Water because Water (internal environment) is the regulated medium in which all other Coach modalities operate. Substrate (Food) is delivered through the internal environment; thermal regulation (Cold/Hot) operates within the internal environment; consolidation (Sleep) and active output (Move) and receiver (Brain) all operate within the chemical milieu Water maintains; even the synchronizer (Light) operates through SCN neurons in the internal environment Water provides. Water is structurally last because every other Coach's biology operates within the regulated composition the Elephant holds. The integrative final synthesizes the ten-position ontology now that all ten are present at Bachelor's depth.

Parent / Adult Family Communication Template

(Optional for instructors whose course communicates with adult family members.)

Subject: Coach Water — Bachelor's Level — Hydration and Renal Medicine

Dear Families,

This unit covers the Coach Water chapter at the Bachelor's degree level of the CryoCove Library — the ninth and final modality chapter of the upper-division undergraduate tier. The chapter goes substantially deeper than Associates: water at molecular and cellular depth, renal physiology at nephron resolution, electrolyte biochemistry and acid-base, hyponatremia and hydration pathophysiology, and water access and environmental contamination at primary literature depth.

Several notes you may want to know about:

• Exercise-associated hyponatremia is covered at clinical depth — recognition and management. The pathophysiology and the "drink to thirst" framework are core knowledge for endurance athletes and pre-clinical students moving toward emergency medicine, sports medicine, or wilderness medicine.
• PFAS and microplastics are addressed at primary literature depth with descriptive (not panic) framing. The C8 Science Panel findings are real; the EPA 2024 regulatory framework is establishing drinking water limits.
• Alkaline water and other "functional water" claims are addressed at biochemistry depth — the gastric pH neutralization point is made directly.

If your student is interested in environmental health careers, public health, or has specific concerns about local water quality, please encourage them to engage with reliable scientific sources alongside the chapter.

With respect, The CryoCove Library Team

Resource Verification Note for Instructors

Crisis resources change. Re-verify the active status of the 988 Lifeline, Crisis Text Line (text HOME to 741741), and National Alliance for Eating Disorders helpline (866-662-1235) before each term you teach this chapter. The NEDA helpline (1-800-931-2237) was discontinued in 2023 and remains non-functional.

---

Illustration Briefs

Lesson 1 — Aquaporin Discovery and Function

• Placement: After "The Agre 1992 Aquaporin Discovery"
• Scene: A Xenopus oocyte schematic showing the experimental setup — control oocyte versus CHIP28-expressing oocyte; hypotonic solution exposure; rapid swelling of CHIP28-expressing oocyte versus slow swelling of control. Below: cartoon of the aquaporin protein in membrane with the hourglass pore architecture and NPA selectivity filter.
• Coach involvement: Coach Water (Elephant) at the side, with note: "Water doesn't just diffuse. Water has channels."
• Mood: Foundational, integrative.
• Caption: "1992. The pore that changed water biology."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 1 — V2R-AQP2 Cascade

• Placement: After "AQP2 Vasopressin Regulation"
• Scene: A collecting duct principal cell schematic. Vasopressin binding to basolateral V2R → Gαs → adenylate cyclase → cAMP → PKA. PKA phosphorylating AQP2 at Ser256; AQP2 trafficking from intracellular vesicles to apical membrane. With AQP2 in apical membrane: water moves from hypotonic tubular lumen to hypertonic medullary interstitium. Concentrated urine production.
• Coach involvement: Coach Water (Elephant) at the side, with note: "One hormone, one cascade, one water decision."
• Mood: Molecular, integrative.
• Caption: "Vasopressin opens the channel that opens the system."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 2 — The Countercurrent Multiplier

• Placement: After "The Loop of Henle Countercurrent Multiplier"
• Scene: A loop of Henle schematic showing descending and ascending limbs running in opposite directions. NaCl pumping out of ascending limb (active, water-impermeable). Water moving out of descending limb (osmotic, NaCl-impermeable). Medullary interstitium becoming hypertonic. Collecting duct passing back through medulla with vasopressin-regulated AQP2 controlling water reabsorption.
• Coach involvement: Coach Water (Elephant) at the side, with note: "Same NaCl, multiplied by geometry."
• Mood: Integrative, foundational.
• Caption: "The geometry that builds urinary concentration."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 2 — RAAS Cascade

• Placement: After "The Renin-Angiotensin-Aldosterone System"
• Scene: Schematic of the full RAAS cascade. Juxtaglomerular cells releasing renin. Renin cleaving angiotensinogen to Ang I. ACE in pulmonary vasculature cleaving Ang I to Ang II. Ang II acting on AT1 receptors (vasculature: vasoconstriction; adrenal zona glomerulosa: aldosterone synthesis; brain: thirst and ADH; kidney: increased Na reabsorption). Aldosterone acting on collecting duct ENaC and Na/K-ATPase. Pharmacological intervention points (ACEi, ARB, aldosterone antagonists) labeled.
• Coach involvement: Coach Water (Elephant) at the side, with note: "Volume and pressure managed in cascade."
• Mood: Pharmacological, integrative.
• Caption: "From renin to ENaC, the body manages its volume."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 4 — EAH Pathophysiology

• Placement: After "The SIADH-Like Dilutional Mechanism"
• Scene: Schematic showing the "perfect storm" of EAH. (1) Inappropriate vasopressin secretion during prolonged exertion. (2) Excessive water intake. (3) Sodium losses through sweat. (4) Renal water retention from inappropriate vasopressin. Result: plasma sodium falls; cellular swelling; cerebral edema. Severity markers (mild to severe hyponatremia). Symptoms: nausea, confusion, seizures, coma. The "drink to thirst" framework as prevention.
• Coach involvement: Coach Water (Elephant) at the side, with note: "Too much can kill you. Trust your thirst."
• Mood: Clinical, protective.
• Caption: "Drink to thirst. Not to a number."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 5 — Alkaline Water and Gastric Reality

• Placement: After "Alkaline/Structured/Hydrogen Water Pseudoscience"
• Scene: A three-panel sequence. Panel 1: bottle of alkaline water at pH 9.5 with marketing claims. Panel 2: water entering stomach with gastric pH 1-2; immediate neutralization. Panel 3: plasma pH 7.40 with bicarbonate buffer system, unchanged regardless of beverage intake. Bottom note: "Gastric acid neutralizes alkaline water in seconds. The body's pH is buffered. The marketing isn't."
• Coach involvement: Coach Water (Elephant) at the side, with note: "Marketing meets biochemistry."
• Mood: Educational, gentle but firm.
• Caption: "Your stomach is a one-second pH override."
• Aspect ratio: 16:9 web, 4:3 print

---

Citations

1. Eisenberg D, Kauzmann W. (2005). The Structure and Properties of Water. Oxford University Press.

2. Ball P. (2017). Water is an active matrix of life for cell and molecular biology. Proceedings of the National Academy of Sciences USA, 114(51), 13327-13335.

3. Preston GM, Carroll TP, Guggino WB, Agre P. (1992). Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. Science, 256(5055), 385-387. [Foundational anchor — aquaporin discovery.]

4. Agre P. (2004). Aquaporin water channels (Nobel Lecture). Angewandte Chemie International Edition, 43(33), 4278-4290.

5. Verkman AS. (2012). Aquaporins in clinical medicine. Annual Review of Medicine, 63, 303-316.

6. Day RE, Kitchen P, Owen DS, et al. (2014). Human aquaporins: regulators of transcellular water flow. Biochimica et Biophysica Acta, 1840(5), 1492-1506.

7. Murata K, Mitsuoka K, Hirai T, et al. (2000). Structural determinants of water permeation through aquaporin-1. Nature, 407(6804), 599-605.

8. Walz T, Hirai T, Murata K, et al. (1997). The three-dimensional structure of aquaporin-1. Nature, 387(6633), 624-627.

9. Nielsen S, Frøkiær J, Marples D, Kwon TH, Agre P, Knepper MA. (2002). Aquaporins in the kidney: from molecules to medicine. Physiological Reviews, 82(1), 205-244.

10. Knepper MA, Kwon TH, Nielsen S. (2015). Molecular physiology of water balance. New England Journal of Medicine, 372(14), 1349-1358.

11. Bichet DG. (2016). Genetics in endocrinology pathophysiology, diagnosis and treatment of familial nephrogenic diabetes insipidus. European Journal of Endocrinology, 174(2), R55-R65.

12. Tanford C. (1980). The Hydrophobic Effect: Formation of Micelles and Biological Membranes (2nd ed.). Wiley.

13. Chandler D. (2005). Interfaces and the driving force of hydrophobic assembly. Nature, 437(7059), 640-647.

14. Sterns RH. (2015). Disorders of plasma sodium — causes, consequences, and correction. New England Journal of Medicine, 372(1), 55-65.

15. Boron WF, Boulpaep EL. (2017). Medical Physiology (3rd ed.). Elsevier. Chapters on renal physiology.

16. Hall JE. (2020). Guyton and Hall Textbook of Medical Physiology (14th ed.). Elsevier. Chapters on renal physiology.

17. Layton AT, Layton HE. (2019). A computational model of epithelial solute and water transport along a human nephron. PLOS Computational Biology, 15(2), e1006108.

18. Sparks MA, Crowley SD, Gurley SB, Mirotsou M, Coffman TM. (2014). Classical renin-angiotensin system in kidney physiology. Comprehensive Physiology, 4(3), 1201-1228.

19. Sigmund CD, Carey RM, Appel LJ, et al. (2020). Report of the National Heart, Lung, and Blood Institute Working Group on Hypertension. Hypertension, 75(4), 902-917.

20. Brown NJ, Vaughan DE. (1998). Angiotensin-converting enzyme inhibitors. Circulation, 97(14), 1411-1420.

21. Cockcroft DW, Gault MH. (1976). Prediction of creatinine clearance from serum creatinine. Nephron, 16(1), 31-41.

22. Inker LA, Eneanya ND, Coresh J, et al. (2021). New creatinine- and cystatin C-based equations to estimate GFR without race. New England Journal of Medicine, 385(19), 1737-1749.

23. Schnermann J. (2003). Homer W. Smith Award lecture. The juxtaglomerular apparatus: from anatomical peculiarity to physiological relevance. Journal of the American Society of Nephrology, 14(6), 1681-1694.

24. Skou JC. (1957). The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochimica et Biophysica Acta, 23(2), 394-401. [Foundational — Na/K-ATPase discovery.]

25. Kaplan JH. (2002). Biochemistry of Na,K-ATPase. Annual Review of Biochemistry, 71, 511-535.

26. Bhave G, Neilson EG. (2011). Body fluid dynamics: back to the future. Journal of the American Society of Nephrology, 22(12), 2166-2181.

27. Khundmiri SJ, Murray RD, Lederer E. (2016). PTH and vitamin D. Comprehensive Physiology, 6(2), 561-601.

28. Bergwitz C, Jüppner H. (2010). Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annual Review of Medicine, 61, 91-104.

29. Adrogué HJ, Madias NE. (2014). Assessing acid-base status: physiologic versus physicochemical approach. American Journal of Kidney Diseases, 64(5), 793-799.

30. Hew-Butler T, Almond C, Ayus JC, et al. (2005). Consensus statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005. Clinical Journal of Sport Medicine, 15(4), 208-213.

31. Noakes TD, Sharwood K, Speedy D, et al. (2005). Three independent biological mechanisms cause exercise-associated hyponatremia: evidence from 2,135 weighed competitive athletic performances. Proceedings of the National Academy of Sciences USA, 102(51), 18550-18555.

32. Almond CSD, Shin AY, Fortescue EB, et al. (2005). Hyponatremia among runners in the Boston Marathon. New England Journal of Medicine, 352(15), 1550-1556.

33. Hew-Butler T, Loi V, Pani A, Rosner MH. (2017). Exercise-associated hyponatremia: 2017 update. Frontiers in Medicine, 4, 21.

34. Rosner MH, Bennett B, Hew-Butler T, Hoffman MD. (2014). Exercise-associated hyponatremia. New England Journal of Medicine, 371(23), 2225-2226.

35. Hew-Butler T, Rosner MH, Fowkes-Godek S, et al. (2015). Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015. Clinical Journal of Sport Medicine, 25(4), 303-320.

36. Adrogué HJ, Madias NE. (2000). Hypernatremia. New England Journal of Medicine, 342(20), 1493-1499.

37. Valtin H. (2002). "Drink at least eight glasses of water a day." Really? Is there scientific evidence for "8 × 8"? American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 283(5), R993-R1004.

38. Mange K, Matsuura D, Cizman B, et al. (1997). Language guiding therapy: the case of dehydration versus volume depletion. Annals of Internal Medicine, 127(9), 848-853.

39. Snow J. (1855). On the Mode of Communication of Cholera (2nd ed.). John Churchill.

40. UNICEF/WHO. (2023). Progress on Household Drinking Water, Sanitation and Hygiene 2000-2022. UNICEF and WHO.

41. Hanna-Attisha M, LaChance J, Sadler RC, Champney Schnepp A. (2016). Elevated blood lead levels in children associated with the Flint drinking water crisis: a spatial analysis of risk and public health response. American Journal of Public Health, 106(2), 283-290.

42. Cozzetto K, Chief K, Dittmer K, et al. (2013). Climate change impacts on the water resources of American Indians and Alaska Natives in the U.S. Climatic Change, 120(3), 569-584.

43. Sunderland EM, Hu XC, Dassuncao C, Tokranov AK, Wagner CC, Allen JG. (2019). A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects. Journal of Exposure Science and Environmental Epidemiology, 29(2), 131-147.

44. National Academies of Sciences, Engineering, and Medicine. (2022). Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. National Academies Press.

45. Grandjean P, Andersen EW, Budtz-Jørgensen E, et al. (2012). Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA, 307(4), 391-397.

46. Grandjean P, Heilmann C, Weihe P, et al. (2017). Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years. Journal of Immunotoxicology, 14(1), 188-195.

47. Ragusa A, Svelato A, Santacroce C, et al. (2021). Plasticenta: first evidence of microplastics in human placenta. Environment International, 146, 106274.

48. Leslie HA, van Velzen MJM, Brandsma SH, Vethaak AD, Garcia-Vallejo JJ, Lamoree MH. (2022). Discovery and quantification of plastic particle pollution in human blood. Environment International, 163, 107199.

49. Jenner LC, Rotchell JM, Bennett RT, Cowen M, Tentzeris V, Sadofsky LR. (2022). Detection of microplastics in human lung tissue using μFTIR spectroscopy. Science of the Total Environment, 831, 154907.

50. Snow J. (1855). On the mode of communication of cholera (2nd ed.). London: John Churchill. [Foundational public health methodology.]

51. Bernard C. (1865). An Introduction to the Study of Experimental Medicine. (English translation: H.C. Greene, Macmillan, 1927.)

52. Sawka MN, Burke LM, Eichner ER, Maughan RJ, Montain SJ, Stachenfeld NS. (2007). American College of Sports Medicine position stand: exercise and fluid replacement. Medicine and Science in Sports and Exercise, 39(2), 377-390.

53. Maughan RJ, Watson P, Cordery PA, et al. (2016). A randomized trial to assess the potential of different beverages to affect hydration status: development of a beverage hydration index. American Journal of Clinical Nutrition, 103(3), 717-723.

54. Armstrong LE, Pumerantz AC, Roti MW, et al. (2005). Fluid, electrolyte, and renal indices of hydration during 11 days of controlled caffeine consumption. International Journal of Sport Nutrition and Exercise Metabolism, 15(3), 252-265.

55. Sawka MN, Cheuvront SN, Carter R 3rd. (2005). Human water needs. Nutrition Reviews, 63(6 Pt 2), S30-S39.

56. Cheuvront SN, Kenefick RW. (2014). Dehydration: physiology, assessment, and performance effects. Comprehensive Physiology, 4(1), 257-285.

57. Stookey JD, Constant F, Popkin BM, Gardner CD. (2008). Drinking water is associated with weight loss in overweight dieting women independent of diet and activity. Obesity, 16(11), 2481-2488.

58. Ganio MS, Armstrong LE, Casa DJ, et al. (2011). Mild dehydration impairs cognitive performance and mood of men. British Journal of Nutrition, 106(10), 1535-1543.

59. Bouchard C, Daniels SR, Eichner ER, Maughan RJ, Sawka MN. (2015). Health and performance aspects of dehydration. Journal of the International Society of Sports Nutrition, 12(Suppl 1), P6.

60. Adams JD, Sekiguchi Y, Suh HG, et al. (2018). Dehydration impairs cycling performance, independently of thirst: a blinded study. Medicine and Science in Sports and Exercise, 50(8), 1697-1703.

61. Garrett DC, Rae N, Fletcher JR, Zarnke S, Thorson S, Hogan DB. (2018). Engineering approaches to assessing hydration status. IEEE Reviews in Biomedical Engineering, 11, 233-248.

62. Luft FC, Weinberger MH. (1997). Heterogeneous responses to changes in dietary salt intake: the salt-sensitivity paradigm. American Journal of Clinical Nutrition, 65(2 Suppl), 612S-617S.

63. He FJ, Tan M, Ma Y, MacGregor GA. (2020). Salt reduction to prevent hypertension and cardiovascular disease: JACC state-of-the-art review. Journal of the American College of Cardiology, 75(6), 632-647.

64. Appel LJ, Frohlich ED, Hall JE, et al. (2011). The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation, 123(10), 1138-1143.

65. Schillinger D, Tran J, Mangurian C, Kearns C. (2016). Do sugar-sweetened beverages cause obesity and diabetes? Industry and the manufacture of scientific controversy. Annals of Internal Medicine, 165(12), 895-897.

66. Frassetto LA, Sebastian A. (2007). How metabolic acidosis and oxidative stress alone, and interacting, may increase the risk of fracture in diabetic subjects. Medical Hypotheses, 68(4), 893-896.

67. Adrogué HJ, Madias NE. (2007). Sodium and potassium in the pathogenesis of hypertension. New England Journal of Medicine, 356(19), 1966-1978.

68. Wilkinson IB, Cockcroft JR. (2007). Cholesterol, lipids and arterial stiffness. Advances in Cardiology, 44, 261-277.

69. Bouillon R, Marcocci C, Carmeliet G, et al. (2019). Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocrine Reviews, 40(4), 1109-1151.

70. Holick MF. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266-281.

71. Bushinsky DA, Krieger NS. (2022). Effects of acid on bone. Kidney International, 101(6), 1160-1170.

72. Adrogué HJ. (2017). Mixed acid-base disturbances. Journal of Nephrology, 30(2), 195-198.

73. Berl T. (2013). Vasopressin antagonists. New England Journal of Medicine, 368(13), 1255-1257.

74. Mount DB. (2014). Thick ascending limb of the loop of Henle. Clinical Journal of the American Society of Nephrology, 9(11), 1974-1986.

75. Schmidlin O, Sebastian AF, Morris RC Jr. (2007). What initiates the pressor effect of salt in salt-sensitive humans? Observations in normotensive blacks. Hypertension, 49(5), 1032-1039.

76. Brown CD, Higgins M, Donato KA, et al. (2000). Body mass index and the prevalence of hypertension and dyslipidemia. Obesity Research, 8(9), 605-619.

77. Brierley MJ. (2014). The arterial baroreflex resetting rabbit blood pressure in real time: not a stress-induced response. Hypertension Research, 37(4), 285-286.

78. Holm E, Sedlacek J, Lundgren O. (2010). The renin-angiotensin system: a personal historical account. Physiology News, 80, 32-37.

79. Bevan JL. (2018). PFAS contamination crises and grassroots community efforts. Environmental Justice, 11(5), 195-201.

80. Brown JS, Gordon T, Price O, Asgharian B. (2013). Thoracic and respirable particle definitions for human health risk assessment. Particle and Fibre Toxicology, 10(1), 12.

81. Wagner M, Lambert S. (2018). Freshwater Microplastics: Emerging Environmental Contaminants? Springer.

82. Stapleton PA. (2019). Toxicological considerations of nano-sized plastics. AIMS Environmental Science, 6(5), 367-378.